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PREFACE

This dissertation consists of four major parts: a
LITERATURE REVIEW, SECTION I, SECTION II, and CONCLUSIONS
AND FUTURE STUDIES. SECTION I AND SECTION II are each
presented in the form of a manuscript. The LITERATURE REVIEW
is intended to provide a comprehensive review of the PFK
literature pertinent to this study, and therefore some
overlap may exist between this part of the dissertation and
the introduction in SECTION I or SECTION II. The DISCUSSION
AND FUTURE STUDIES part of this work summarizes the results
of this research and I have proposed in this part several
experiments to further our understanding of the regulation
of the rmPFK gene. Again, some overlap may be found between
this part and the discussion of either SECTION I or SECTION
II.
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ABSTRACT

Phosphofructokinase (ATP:Fructose- 6-phosphate 1-phospho
transferase, EC 2.7.1.11, PFK) catalyzes the phosphorylation
of fructose 6-phosphate to generate fructose 1 ,6 bisphosphate, the rate-limiting step of glycolytic pathway.
Li et a l . (1990) have identified two cDNAs for the rabbit
muscle PFK with an identical coding regions but different 5'
untranslated regions

(UTRs). In this dissertation research,

six cDNAs for the rabbit muscle PFK mRNAs were cloned. These
cDNAs are different in their 5' UTRs but have an identical
open reading frame. The transcription initiation sites of
two downstream promoters of this gene have been determined.
A proximal promoter

(Pa) is TATA-less and 86 bp upstream of

the ATG start codon. The mRNA expressed from this promoter
has been detected in skeletal muscle and heart tissues. The
second promoter

(Pb) is skeletal muscle specific and

produces two mRNAs

(mRNA-bl and mRNA-b2) by alternative

splicing. Part of the 5' UTR in mRNA-bl is spliced out to
yield mRNA-b2. A fourth mRNA (mRNA-c) is also skeletal
muscle specific.
An additional two mRNAs (mRNA-dl and -d2) are produced by
alternative splicing. An exon of 106 bp was retained in
mRNA-dl, but not in mRNA-d2. Interestingly, mRNA-dl was
detected in skeletal muscle, heart, and brain, but not in
liver and kidney tissues. Its splicing variant, mRNA-d2 is
detected in all five tissues examined. Therefore, the 106 bp
ix

exon is retained in a tissue-specific manner. Since the 5'
ends of mRNA-c, -dl, and -d2 are upstream of promoters a and
b, these mRNAs can not be produced by these promoters.
Therefore, rmPFK expresses its six mRNAs by at least three
promoters and alternative splicing.
During the course of this research,

I have developed a

protocol for primer extension at higher temperature. In
primer extension using M-MLV reverse transcriptase, a
secondary structure of the RNA template was found to be
problematic. I therefore optimized conditions for primer
extension using thermostable DNA polymerase from Thermus
thermophllus at high temperature. The primer extension at
high temperature (65°C) using this enzyme reduced the
artifact caused by the secondary structure in the RNA
template.
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In glycolysis, glucose is degraded to generate ATP, NADH,
and pyruvate. Pyruvate is further converted to acetyl CoA,
providing building blocks for other synthetic reactions,
such as the formation of long-chain fatty acids (Fig. 1). In
glycolysis, phosphofructokinase (ATP: D-fructose- 6-phosphate
1-phosphotransferase, EC 2.7.1.11, PFK) catalyzes the
phosphorylation of fructose- 6-phosphate
produce fructose-1, 6-bisphosphate
(Bloxham and Lardy,
pathways,

1973; Uyeda,

(F-6-P) by ATP, to

(F-1,6-BP) and ADP
1979; Fig. 2). In metabolic

enzymes catalyzing essentially irreversible

reactions are potential sites of control. In glycolysis, the
reactions catalyzed by three enzymes (hexokinase,
phosphofructokinase, and pyruvate kinase) are irreversible.
Therefore, these enzymes are potential sites of control in
the glycolytic pathway. Hexokinase catalyzes the first
irreversible reaction, the phosphorylation of glucose to
produce glucose 6-phosphate. This product is not only a
glycolytic intermediate, but can also be oxidized by the
pentose phosphate pathway to generate NADPH or be converted
into glycogen. Although PFK catalyzes the second
irreversible reaction, this reaction is the first committed
step in glycolysis, and therefore the most important control
site in glycolysis

(Bloxham and Lardy, 1973; Uyeda,

1979).

One of the best known examples of PFK as the control site of
glycolysis is its role in the Pasteur effect

(inhibition of
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fermentation by oxygen). In studying fermentation of yeast,
Pasteur found that fermentation is inhibited by oxygen. The
rate of fermentation is about seven fold lower under aerobic
conditions than under anaerobic conditions. This inhibition
is largely due to the inhibition of PFK activity by ATP and
citrate, because the product of PFK, F-1,6-BP was readily
fermented in the presence of oxygen (reviewed in Dunaway,
1983; Bloxham and Lardy,

1973).

The physiological significance of PFK is examplified in
the hereditary PFK deficiency in human skeletal muscle,
known as the type VII glycogenosis, or Tarui disease
et al.,

(Tarui

1965). The symptoms of this disease include

intolerance to muscular exercise,

increased hemolysis, and

hyperuricemia (Tarui et a l ., 1965; Nakajima et a l ., 1990).
The patients with this disease have no PFK activity in their
skeletal muscle

(Tarui et al., 1965).

REGUXJkTXON

MANHXLIAM

OF

PFK

ACTIVITY

BY

BFFECTOR8

Mammalian PFKs are allosteric enzymes. Tetramers are the
smallest active form for PFK isolated from mammalian sources
(Dunaway,

1983). Each tetramer has several effector binding

sites in addition to the substrate binding sites. Binding of
effectors, either inhibitors or activators allosterically
changes the kinetic properties of this enzyme. As mentioned
above, PFK is inhibited by ATP and citrate. On the other
hand, PFK is activated by inorganic phosphate

(Pi), AMP,

cyclic AMP, ADP, GDP, and its product F-1,6-BP. The
regulations of mammalian PFKs by the effectors are very

6
complex (Bloxham and Lardy,

1973). Here, only several major

features of such regulations are summarized below:
1. The enzyme is inhibited by a high concentration of
ATP .
2. The enzyme is also inhibited by citrate, an
intermediate in the Krebs cycle. This inhibition is
synergistic with that by ATP.
3. The inhibition by ATP can be relieved by Pi, AMP,
cyclic AMP, ADP, F-1, 6-BP, and F-2,6-BP.
4. Binding of substrate F- 6-P is cooperative. Inhibitors
decrease the affinity of PFK to F- 6-P, while the activators
increase the affinity.
The inhibition of rabbit PFK activity by ATP was first
reported by Lardy and Parks (1956). Increasing the
concentration of ATP above that necessary for the optimum
catalytic activity causes a progressive decrease in PFK
activity. This allosteric effect results from the decreased
affinity for F- 6-P upon the binding of ATP to the effector
site. As the concentration of F- 6 -P is increased, the effect
of ATP inhibition is reduced (Mansour and Ahlfors,

1968).

The inhibitory effect of ATP is counteracted by the
metabolic degradation products of ATP, including Pi, AMP,
and ADP (Bloxham and Lardy,

1973). Thus, PFK activity is

closely regulated in relation to physiological conditions:
high ATP/ADP ratio inhibits PFK activity, while high ADP/ATP
ratio activates the PFK activity.

7
The pH of the medium also affects the inhibition of ATP.
At pH 7.0 and with saturating ATP, rabbit muscle PFK is
inhibited by ATP and exhibits sigmoidal kinetics with
respect to F- 6-P. At pH 8.0, however, ATP inhibition and
cooperativity are not observed (Hanson et al.,

1973) .

Similar results have also been reported for PFKs from brain
(Tsai and Kemp, 1974; Lowry and Passonneau,
(Mansour and Ahlfors,

1966), heart

1968), and liver (Kemp, 1971).

Citrate is also an important inhibitor of PFK activity.
This links the regulation of glycolysis with the Krebs
cycle. Using rat heart PFK, Garland et a l . (1963) found that
citrate is the only Krebs cycle intermediate effective in
inhibiting PFK activity. However, muscle PFK has been found
to be inhibited also by isocitrate, though less than by
titrate (Parmeagiani and Bowman,

1963). Rat brain PFK is

inhibited by most of the Krebs cycle intermediates,
including cis-aconitate,
a-ketoglutarate

isocitrate, malate,

(Passonneau and Lowry,

succinate, and

1963). Tsai and Kemp

(1974) observed that rabbit muscle PFK is more sensitive to
citrate inhibition than the liver or brain PFK. The
inhibition by citrate has been shown to be synergistic to
that of ATP (Passonneau and Lowry,

1963). Mammalian PFK is

also inhibited by several other phosphorylated
intermediates,

including phosphocreatine,

3-phosphoglycerate, 2,3-bisphosphoglycerate, and
phosphoenolpyruvate

(Bloxham and Lardy, 1973; Uyeda,

1979).

The inhibition by these inhibitors is most pronounced in the

8
presence of an inhibitory concentration of ATP (Colombo et
al., 1975),
The inhibition by ATP and other negative effectors can be
counteracted by AMP, cAMP, ADP, Pi, F- 6 -P, and F-1,6-BP
(Uyeda,

1979; Pilkis et al., 1981). F-1,6-BP is the

strongest activator. The activation of PFK by positive
effectors are synergistic. For instance, activation by
F-1,6-BP is enhanced by AMP

(Tornheim and Lowenstein,

1976).

ADP alone is a weak activator and the presence of Pi greatly
enhances the activation by ADP (Passonneau and Lowry,

1963) .

In the early 1980s, a new regulator of glycolysis was
discovered (Van Schaftingen et al., 1980; Claus et al. 1981;
Uyeda et a l ., 1981). Van Schaftingen et a l .(1980) found that
fl-D—fructose-2,6 -bisphosphate (F-2,6-BP), a previously
unknown metabolite, is a positive effector of PFK. Like
other positive effectors, F-2, 6-BP activates PFK by
increasing its affinity for F- 6-P and relieving the
inhibitory effect of ATP. This effector is the most potent
activator known. For the liver PFK, the concentration of
F-2, 6 -BP needed to achieve a half-maximal stimulation is
1000 times lower than that of F-1,6-BP required to obtain
the same effect

(Van Schaftingen et a l ., 1980). The affinity

of the rabbit muscle PFK for F-2, 6-BP is approximately 10
fold higher than that for F-1,6-BP

(Foe et al., 1983).

The level of F-2, 6 -BP has been shown to be regulated by
hormones.

Insulin and epinephrine, both of which stimulate

lactate production, also increase the concentration of

9
F-2, 6-BP. F-2, 6 -BP is synthesized and degraded by
6-phosphofructo- 2 -kinase/fructose- 2 ,6-bisphophatase

(6PF-2-K/F-2,6-BPase), a bifunctional protein. The two
reactions are catalyzed at two discrete active sites.
6PF-2-K/F-2, 6-BPase is a dimeric protein and is regulated by
reversible phosphorylation (Pilkis, 1990) . The hormones
regulate the F-2, 6-BP level by phosphorylating or
dephosphorylating the protein via a cyclic AMP mediated
signal transduction pathway

(Pilkis and El-Maghrabi,

MAMMALIAN

THREE

PFK

EXISTS

AS

1988).

ISOZYMES

The possible existence of isozymes of mammalian PFK was
first implicated in the aforementhioned Tarui disease that
is characterized by lack of muscle PFK activity (Tarui et
al., 1965; Layzer et al,, 1967).

In patients with this

disease, although the muscle PFK activity was reduced to
zero, erythrocyte PFK activities were half of normal, and
the PFK activities in white blood cells were unaffected
(Layzer et al., 1967). Immunological studies showed that an
antibody against human muscle PFK failed to inhibit
erythrocyte PFK from these patients, while normal
erythrocyte PFK activity was inhibited approximately 40%
(Layzer et al., 1969; Tarui et al., 1969). These
observations suggest that the enzymes from muscle and
erythrocyte are products of different genes.
In rabbit tissues, there are three isozymes
Kemp,

1985; Gonzalez and Kemp,

1974; Kemp,

(Foe and

1978; Tsai and Kemp,

1971). The three isozymes purified from

1973;
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different tissues were named as M from muscle, L from liver,
and C from brain

(Kemp, 1971; Tsai and Kemp,

1974; Foe and

Kemp, 1985). The apparent monomer molecular weight of the L,
M, and C subunits are 80,000, 85,000, and 87,500,
respectively (Dunaway, 1983). The three isozymes are
immunologically distinct. Antiserum against purified muscle
PFK removed 98% activity from solution containing purified
muscle PFK, but removed only partial activity

(32%) of

purified liver enzyme. Antiserum against purified liver PFK
removed 96% activity of the purified liver PFK, but removed
a mere 3% activity of the purified muscle enzyme. The
combination of both antisera did not remove all the brain
PFK activity, because the C type isozyme also is found in
this organ

(Tsai and Kemp, 1973). Antisera raised against

muscle or liver PFK removed litle purified PFK C activity
(Foe and Kemp,

1985). When the protomers of acid dissociated

muscle and liver PFK recombine at neutral pH, they form
three electrophoretically distinct isozymes in addition to
the two parent enzymes. This result agrees with the concept
that muscle and liver PFKs are different proteins. The three
hybrids are be M 3L, L 3M, and M 2L2 (Gozaie2 and Kemp,

1978),

In human and rat tissues, there are also three isozymes
(Dunaway, et al., 1988; Dunaway and Kasten,

1987). in

general, mammalian PFK exists as a homo- or hetero-tetramer
of the three subunits, depending on the abundance of the
three subunits in a given tissue (Dunaway, 1983).
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MAMMALIAN

PFKS

ARC

HIGHLY

CONSERVED

The complete primary structures of the three isozymes of
mammalian PFKs have been determined. The M isozyme has been
cloned and sequenced from rabbit

(Poorman et al., 1984; Lee

et a l ., 1987), mouse (Gehnrich et al., 1988), and human
muscles

(Sharma et al., 1989). The L isozyme has been cloned

and sequenced from rat (Hotta et al., 1991), mouse

(Gekakis

et al, 1989), and human (Levanon et al., 1989) livers. The C
isozyme has been determined from rabbit
and rat

(Li et a l ., 1994),

(Gekakis et al., 1994) tissues.

Comparison of the amino acid sequences of the three types
of mammalian PFK isozymes indicates that all mammalian PFKs
are highly homologous: there is more than 65% ammino acid
sequence identity among the cloned mammalian PFK isozymes
(Gekakis et al., 1994). Interestingly, there is higher
sequence identity between the same type of isozymes from
different species than between two types of isozymes from
the same species. For example, there is only 68.9% amino
acid sequence identity between rabbit M and C type PFKs,
while there is 90% sequence identity between the rabbit
muscle and mouse muscle PFKs (Lee et al., 1987; Gehnrich et
al., 1988; Li et al., 1994). Perhaps, different PFK isozymes
evolved before the mammals diversified.

TISSUE SPECIFICITY
PROTEIN LEVEL

OF

THE

PFK

ISOEYMES

AT

THE

The levels of the three PFK subunits in mammalian tissues
have been studied by SDS-polyacrylamide gel electrophoresis
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and immunoprecipitation with antisera raised against each
type of subunit. The tissue-specific distributions of the
three types of PFK isozymes in human, rabbit, and rat are
summarized in Table 1. In skeletal muscle, only the M
subunit has been detected in rabbit
rat

(Dunaway and Kasten,

(Tsai and Kemp,

1973),

1987), and human (Dunaway et al.,

1988). In liver, the L type subunit is the predominant form.
But there are small amounts of the M type subunit in rabbit
(Tsai and Kemp,

1973), and rat liver (Dunaway and Kasten,

1987), and small amounts of the M and C type subunits in
human liver (Dunaway et a J ., 1988). The M type PFK is the
major form in the heart of all three mammals, along with L
and C type subunits

(Tsai and Kemp,

1988; Dunaway and Kasten,
rabbit

1973; Dunaway et al.,

1987). In the brain and kidney of

(Tsai and Kemp, 1973), rat

(Dunaway and Kasten,

1987), and human (Dunaway et a l ., 1988), all three types of
subunits co-exist. The three subunits have also been
detected in other rat tissues, such as lung, thyroid, and
spleen (Dunaway and Kasten, 1987).

THE DISTINCT KINETIC PROPERTIES
MAMMALIAN PFK ISOZYMES

OF

THE

THREE

Kemp (1971) observed that the rabbit muscle and liver
PFKS are different kinetically. He found that the liver
enzyme is more sensitive to ATP and 2,3-diphosphoglycerate
inhibition, less sensitive to citrate and phosphoenopyruvate
(PEP) inhibition, and less sensitive to activation by AMP,
ADP, and cAMP. He concluded from these results that liver

Table 1. Tissue-specific expression patterns of the three mammalian PFK
isozymes in human, rabbit, and rat tissues.

Human*
Isozyme

M

C-type
M-type
L-type

+♦++

R ab b itb

L

K

H

B

+

•M-

+♦

•M+

+

**

■M+

**

♦+

♦♦♦»

M

♦+++

L

*

K

R atc
H

B

M

L

K

H

B

♦+

♦+

+++

+++

++

++++ ++

++

•: Dunaway et al. (1988).
b: Tsai and Kemp (1973).
c: Dunaway and Kastan (1987).
M: muscle; L: liver; K: kidney; H: heart; B: brain.
++++: predominant (>80%); +++: major (50-70%); ++: abundant
+ : small amount (<10 %).

++

(10 -40%);
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PFK was less suited for anaerobic energy production than
muscle PFK. Gonzalez and Kemp (1978) compared the kinetics
of the M 2L2 hybrid isozyme of rabbit PFK with those of the
M 4 and L 4 isozymes. They found that ATP inhibition to the
hybrid enzyme is intermediate between that observed with M 4
and L 4 and is clearly not identical to a simple summing of
the effects of M and L subunits. The inhibitions to the M 2L2
hybrid by citrate, 2 ,3-diphosphoglycerate, and
phosphocreatine are also intermediate between those observed
with M 4 and L4 .
The kinetic properties of the C type PFK remained elusive
for a while, partly because it co-exists with the other two
isozymes in a given tissue, such as brain, which makes it
more difficult to purify. Almost a dacade and a half after
purification of the M and L isozymes, Foe and Kemp (1965)
successfully purified PFK C from rabbit brain. They found
that this isozyme is kinetically distinct from the M and L
isozymes. The C isozyme is more sensitive than the M isozyme
but less sensitive than the L isozyme to ATP inhibition. The
inhibition by citrate is opposite: the C isozyme is less
sensitive than the M isozyme but more sensitive than the L
isozyme to citrate inhibition, PFK M is the most sensitive
isozyme to activations by Pi, AMP, ADP and F-2,6~BP, while
isozyme C is the least sensitive to these activators
and Kemp,

(Foe

1985). They again noted that the kinetic

properties of PFK hetero-tetramers are probably influenced
by interactions between the different subunits, since their
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kinetics cannot be predicted from the properties of the
homo-tetramers.
These distinct kinetic properties of the three mammalian
isozymes probably evolved according to the physiological
requirement of glycolytic regulation in a given tissue. For
example, PFK M is the least sensitive to ATP inhibition but
the most sensitive to positive effectors such as AMP, ADP,
and F-2,6-BP. This fits well with the physiology of muscle,
where ATP is produced and utilized for muscle movement.
Hepatocytes have very different requirements since they must
be capable of carrying out gluconeogenesis in order to
maintain blood glucose levels. Citrate and other Krebs cycle
intermediates are also precursors in gluconeogenesis. They
are oxidized to yield oxaloacetate, which in turn is
converted into phosphoenolpyruvate, an intermediate in
gluconeogenesis. Therefore, the L type PFK, the least
sensitive to citrate inhibition, allows glycolysis and
gluconeogenesis to be carried out in the hepatocytes.

STRUCTURE

OF

BACTERIAL

PVKS

The structure of the bacterial PFK is reviewed here for
two reasons. First, the three-dimensional structure of
mammalian PFK has not been determined. Second, mammalian
PFKs probably evolved by gene duplication, because the Nand C-terminal halves of the rabbit muscle PFK are
homologous to each other and to bacterial PFKs (Poorman et
al., 1984; Lee et al.,

1967), Poorman et a l . (1984) proposed

a model structure of the rabbit muscle PFK based on the
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structure of bacterial PFK (I will come back to this in more
detail later).
PFK from Bacillus stearothermophllus and that from
Eschericha coll are highly homologous, with 53% amino acid
identity. The E . coli PFK (EcPFK) shows sigmoidal kinetics
with respect to one substrate, F- 6-P, but not to the other
substrate, ATP. It is allosterically inhibited by PEP, and
allosterically activated by ADP or GDP. The B. stearothermophllus PFK (BsPFK) behaves similarly, except that the
kinetics with respect to F- 6-P are sigmoidal only in the
presence of PEP. In the absence of PEP, it is hypobolic
(Valdez et a l ., 1989a).
The three-dimensional structures of EcPFK and BsPFK have
been determined using X-ray crystallography (Evans et al.,
1981; Shirakihara and Evans, 1988; Schirmer and Evans,
1990). The structure of the enzyme bound to substrate and
effector reveals the mechanism of the catalysis and the
effector binding. Comparison of the structures of the BsPFK
in the relaxed

(R) and tight (T) states shows how the

conformation is changed before and after the allosteric
transition, which provides insight into the mechanism of the
allosteric behavior of PFK (Schirmer and Evans, 1990).
Both E. coli and B. stearothermophilus PFKs are tetramers
of identical subunits with 319 amino acids each. Each
subunit consists of two domains: a larger one which binds
the substrate ATP, and a smaller one which binds the other
substrate F- 6 - P . Each domain is a 3-layered a p a sandwich
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structure. The tetramer is a dimer of dimers: two subunits
pack together with a large interface to form dimers
(subunits AB or CD in Fig. 3) and two dimers pack together
with a smaller interface to form the tetramer. The tetramer
exhibits 222 symmetry: the three molecular dyad axes are p,
q, and r (Fig. 3).
The active site lies between the two domains of each
subunit: the ATP binding site is formed almost entirely by
residues of the large domain and the F- 6 -P binding site
consists of residues mainly from the small domain
(Shirakihara and Evans, 1988). The catalytic site is located
between the two domains, while the effector site lies in the
larger interface between the two subunits within each dimer
(Schirmer and Evans, 1990).

STRUCTURE

DIFFERENCES

OF

BSPFK

IN THE

R

AMD

T

STATES

When the structures of the R and T states are
superimposed on their 222 axes, the major difference is the
rotation of the AB dimer relative to the CD dimer by about
7° (Fig. 3). The rotation axis is close to the molecular p
dyad (the symmetry axis of the dimers). Not much rotation is
seen between the two subunits of the dimer, because of the
much larger contact area between subunits within the dimer
as compared to that between dimers. Although no significant
change has been noted at the large interface of the two
subunits within the dimer, an additional hydrogen bond
exists between the subunits in the T state. Asp 59 interacts
with the ribose of the effector ADP in the R structure, and
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3 . Diagram depicting the general view of BsPFK and
its quaternary and tertiary structure changes on the
allosteric transition from R to T, a. Schematic sketch of
the R-state (dashed outline) and T-state (solid outline)
PFK tetramer, viewed along p. The three mutually
perpendicular 2-fold symmetry axes are labeled p, g and r.
The subunits are labeled A-D. Residues labeled with *
belong to subunit A, all others to subunit D. b, same as
in a but viewed from r and additional presentation of the
ligands of the R structure.
(adapted from Schirmer and
Evens, 1990). e, R-state structure, subunits A and D,
related by r dyad, viewed as in b. helices are presented
as cylinders numbered 1-13, 0-sheet strands as arrows
labeled A-K. In the active site the substate F - 6-P and the
product ADP are shown, in the effector site the activator
ADP (Shirmer and Evens, 1990). (Reprinted with permission
from Nature 343, 140-145; Copyright (c) 1990 MacMillan
Magazines Limited)
Figure
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is hydrogen bonded to His 215 in the neighboring subunit. On
the other hand, the interface between the two dimers
triggers and accommodates their relative rotation in the
allosteric transition. On transition from the R to the T
state, the rigid dimers undergo a contrary rotation around
their common dyad axis. This motion couples the changes in
the four binding sites for the cooperative substrate F- 6 -P,
which lie between dimers. The rotation of the dimers is
accommodated by removal of the layer of water molecules that
lie between the dimers in the R structure, and by
restructuring the 6-F loop (residues 155-162).
The rearrangement of the 6-F loop couples the binding of
F- 6 -P to the quaternary structure change, and to the binding
of heterotropic effectors (Fig. 4). When molecules with
opposite allosteric effects bind to the effector site, most
of the site remains unchanged. Only the 8 -H loop (residue
213-215) moves in response to a change of effector. This
movement is coupled to the rearrangement of the 6 -F loop.
The low-affinity T-state conformation can only be formed
when the lips of the effector site are closed. This closure
is induced by inhibitors, but cannot occur when the larger
activator ADP is bound, hence the opposite effects
and Evans,

1990).

STRUCTURE

OF

MAMMALIAN

(Schirmer

PFKS

Each subunit of Mammalian PFK has a molecular mass of
85±5 kDa, about twice that of its bacterial counterpart
kDa). Examination of the amino acid sequence of rabbit

(37
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from Nature 343, 140-145; Copyright (c) 1990 MaMillan
Magazines Limited)
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muscle PFK has revealed that its N-terminal and C-terminal
halves are homologous to each other (30% identity). The two
halves of the rmPFK are also homologous to bacterial PFK:
there are 42% and 33% identities between the amino acid
sequence of BsPFK and those of the N- and C-terminal halves
of rmPFK, respectively (Fig. 5). These data suggest that the
mammalian enzyme evolved from a prokaryotic progenitor by
gene duplication and divergence

(Poorman et a l ., 1984; Lee

et al., 1987). Based upon the sequence data, Poorman et a l .
(1984) proposed that the tertiary structure of each rmPFK
subunit consists of two "super" domains, each closely
resembling the structure of the BsPFK monomer,

joined by a

connecting peptide of about 30 residues. Therefore, a
tetramer of mammalian PFK is equivalent to an octomer of
bacterial PFK. Yet, there are only four F- 6 -P binding sites
in a tetramer of mammalian PFK. In addition to the four F- 6P binding sites, there are four binding sites for F-1,6-BP
or F-2, 6-BP (Fig. 6 ), but none in bacterial PFK. This is
probably the structural basis why the bacterial PFKs are not
allosterically regulated by either F-1,6-BP or F-2, 6 -BP.
Homology in the vicinity of Asp-127 in BsPFK, a residue
involved in F- 6 -P binding,

is clearly evident in the N-

terminal half of rmPFK but not in the C-terminal half, where
the corresponding residue is a serine. Poorman et a l . (1984)
postulated that the F- 6-P binding site in the C-terminal
half of rmPFK has evolved as an effector site for either
F-1,6-BP or F-2, 6 -BP, This seems reasonable as Asp-127 is

23

Figure S. Sequence comparison of homologous PFKs and
position of introns along the amino acid sequence of
rabbit muscle PFK. The amino sequence of E. coli PFK
(Ec PFK-1), B . stearothermophilus PFK Bs PFK), and the Nhalf [RM-PFK (N)) and C-half [RM-PFK (C)] of the rabbit
muscle PFK are aligned for maximum homology. Double headed
arrows above the sequences indicate secondary structural
elements found in BsPFK. Introns (solid triangles in the
N- and C- halves of the rabbit muscle PFK are positioned
between the respective amino acid residues. Underlined
regions are those deduced from DNA sequence of the rmPFK
gene.(modified from Hellinga and Evens, 1985 with
permission)
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C-HALF. SUBUNIT 2

N- AND C -H A LV E S O F A SINGLE SUSUMT

y.ifj

«m

N-HALF SUBUM T 1

Figure 6 . Location of substrate
hypothetic rmPFK protein model.
boxes are identical to those at
BsPFK; those enclosed in dotted
with permission from Poorman et

and effector sites in the
Residues enclosed in solid
corresponding positions in
boxes are different (Taken
al., 1984)
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probably required as a base catalyst acting to increase the
nucleophilicity of the 0-1 hydroxyl of F- 6-P for attack on
the y-phosphate of ATP. Its presence would cause
electrostatic repulsion of F-1,6-BP or F-2, 6-BP. Replacement
of Asp-127 by Ser in the C-terminal half would remove this
negative charge and provide more room for binding of the F1,6-BP and F-2, 6-BP, which are known to compete for a common
site (Foe et al., 1983), Poorman et al.

(1984) suggested

that the replacement of a catalytically essential Asp-127
has led to loss of a catalytic site and creation of an
allosteric site for F-1,6-BP or F-2, 6-BP activation.

MAMMAL IAM

PFK

GENES

The first mammalian PFK gene cloned was the rabbit muscle
PFK (Lee et al., 1987). The organization of the rabbit
muscle PFK gene is shown in Figure 7, This gene has 22
coding exons, spanning 17 kp (Lee et al., 1987). When
overlaid on the structure of the protein, most of the
introns are located between or near the ends of the
secondary structural elements. Although the two halves of
the PFK are homologous to each other in amino acid sequence,
the introns located in the carboxyl-terminal half of the
gene are not located at positions analogous to those in the
amino-terminal half (Lee et al., 1987).
Subsequently to the cloning of the rabbit muscle PFK
gene, the mouse liver gene (Rongnoparut et al., 1991) and
human muscle gene (Yamasaki et al., 1991) have been cloned.
Comparison of these three cloned mammalian PFK genes showed
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Figure 7. Exon/intron organization of the rabbit muscle
PFK gene and comparison of the 5' UTRs of two rabbit and
three human muscle PFK cDNAs , a. The complete exon/intron
organization of the rmPFK gene. Solid boxes: coding exon 1
through XXII; open boxes: 5' U T R . The 1.69 kb intron in
rmPFK cDNA-A is indicated by the downward bent line. The
open box with a broken end indicates a UTR, the 5' end of
which is not known, b. Three cDNAs for the human muscle
PFK. The dashed line and box indicate an intron with
unknown length and 5' UTR (Modified from Li et al, 1990),
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that the exon-intron organizations of these genes are
similar with respect to the exon sizes and positions/ with
only one exception: exon 13 in mouse liver gene is three
nucleotides

(1 amino acid) shorter than those in rabbit and

human muscle gene. However, the sizes of the introns in the
three genes are not conserved.

TWO CDNAS Or THI RABBIT
5' UNTRANSLATED REGIONS

MUSCLE
(UTRS)

PFK WITB

DIVERGED

Previous work in the Chang Laboratory has
identified two cDNAs for rmPFK (Li et al., 1990). These
two cDNAs have identical coding regions, but
different 5' untranslated regions

(Figs. 7 and 8 ; Li

et al., 1990). Alignment of the cDNA sequences with
that of the genomic DNA showed that there is an intron
spliced out in the 5' untranslated region of one of the
two cDNAs

(Fig. 7). These cDNAs could be derived from

one promoter and alternative splicing of the pre-mRNA.
Alternatively, they could be produced by two different
promoters.

EUKARYOTIC PRE-nRMA
S P LICEOSOME

SPLICING

IS

FACILITATED

BY

Since the two rmPFK cDNAs could be derived by alternative
splicing, the splicing of pre-mRNA and subsequently the
regulation of alternative splicing are reviewed here.
Splicing of eukaryotic precursor messenger RNA (pre-mRNA)
is a two-step transesterification reaction which precisely
removes the introns and joins exons. The first cleavage
occurs at the 5' splice site, forming cleaved exon I and
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cDNA-A

CTCTCCGGAG CSTATAAAACG TGAGAGGGGC AGCCTGCTGA CCCCCAATCT

cDNA-A
c d n a -B

AGTCCAAACC CTTCTTAGTG CATAAGAAGC TGTTCAAGTC CCACACAAGG
TGTCC TAACTGACCA TCGTCTTGCC

cDNA-A
cDNA-B

TATTAOAflTG C A T C A T Q A C C C A T _O A A ____
T T C T A O A O T Q O A T C A T Q A C C C A T -O A A ---M
T
■
X ----

Figure 8 . Sequence diversity in the 5' UTRs of two rmPFK
cDNAs Bold prints indicate identical sequences. Plain
prints are divergent sequence. "TATA" sequence is
underlined. Coding sequences downstream of ATG are
identical in the two rmPFK cDNAs. M, methionine; T,
threonine; H, histidine; E, glutamic acid. (Modified from
Li et al, 1990)
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lariat intron-second exon intermediates. This is followed by
a second cleavage at the 3' splice site, the concomitant
joining of the two exons, and the release of the intron in
a lariat form (for recent reviews, seeGreen,

1991; Steitz,

1992; Moore et a l ., 1993).
The splicing of pre-mRNA is facilitated by the
spliceosome, which is formed by the assembly onto the premRNA of five small ribonucleoprotein particles (Ul, U2, U4,
U5, and U 6 snRNPs). The assembly of spliceosome in mammalian
cells depends on a consensus sequence at the 5' splice site,
a branch point sequence and the adjacent polypyrimidine
tract, and the 3' AG dinucleotide. The assembly of the
spliceosome starts with the binding of Ul snRNP to the 5'
splice site of the pre-mRNA. This recognition is facilitated
by base-pairing between the 5' end of Ul snRNA and the 5'
splice site (Siliciano and Guthrie,

1980). The second step

is the binding of U2 snRNP to the pre-mRNA branch site.
Base-pairing between U2 snRNA and the branch site of premRNA is involved in this recognition (Wu and Manley,
The biding of

1989).

U2 auxiliary factor (U2AF) to the

polypyrimidine tract near the 3' splice site is also
required for this U2 snRNP-pre-mRNA interaction (Green,
1991). The final step of the spliceosome assembly is the
entry of U4/U6/U5 tri-snRNPs
1993; Green,

(Steitz, 1992; Moore et al.,

1951). U5 snRNA interacts with sequences at

both the 5' and 3' splice sites (Newman and Norman,

1992;

Wassarman and Steitz, 1992) . U 6 snRNA has also been found to
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interact with the intron sequence at the 5' splice site
(Wassarman and Steitz, 1992). Furthermore, the base-pairing
between the U 6 snRNA and the 5' splice site sequence has
been shown to be important and necessary in the 5' splice
site selection
Seraphin,

(Lesser and Guthrie,

1993; Kandels-Lewis and

1993).

Several non-snRNP proteins are also required in the premRNA splicing (Lamm and Lamond,

1993). The cytoplsmic

extract S100 was found to be imcompetent in in vitro
splicing assay, although it contains all the snRNPs required
for pre-mRNA splicing. Addition of alternative splicing
factor/splicing factor 2 (ASF/SF2) is sufficient to render
the S100 extract splicing competent

(Ge and Manley,

1990;

Krainer et al., 1990). ASF/SF2 is a member of the SR protein
family, which includes SRp20, ASF/SF2, SC35, SRp40, SRp55,
and SRp70 in mammals

(Zuo and Manley,

1993; Ge and Manley,

1990; Ge et al.,1991; Krainer et al., 1990, 1991; Zahler et
al., 1992; 1993; Mayeda and Krainer 1992; Mayeda et al.,
1992, 1993; Fu et al., 1992). These proteins contain one or
more RNP-type consensus sequence (RNP-CS) and sequences of
consecutive arginine

(R) and serine (S) dipeptides

(RS

domain). ASF/SF2 and SC35 are involved in the commitment
complex (containing pre-mRNA and Ul snRNP)

formation (Kohtz

et al., 1994; Fu, 1993), by binding to the 5' splice site
(Zuo and Manley,

1994). ASF/SF2 can bind to Ul snRNP, and

more specifically, to the integral Ul 70k protein
a l ., 1994; Wu and Maniatis,

(Kohtz et

1993). This protein-protein

interaction cooperates in the binding of Ul snRNP and
ASF/SF2 to the pre-mRNA (Kohtz et al., 1994). ASF/SF2 and
SC35 are also shown to interact with the 35K subunit of
U2AF, which binds to the polypyrimidine tract near the 3'
splice site. This interaction is thought to bridge the 5'
and 3' splice sites (Hu and Maniatis,

REGULATED

ALTERNATIVE

SPLICING

IN

1993).

HIGHER

EUKARYOTES

Utilizing alternative 5' or 3' splice sites results in
alternative splicing of pre-mRNAs. Alternative splicing of
many genes has been reported to play important roles in
developmental and cellular processes of higher organisms
(for recent reviews, see Maniatis,
Ginard et al., 1991; Rio,

1991; Green, 1991; Nadal

1992). For example, the sex

determination of Drosophila melanogaster requires sexspecific alternative splicing of at least three genes that
are involved in this process (Fig. 9; Baker,

1989). Another

example is the alternative splicing of HIV RNA which plays
important roles in HIV proliferation (Chang and Sharp,
1989). Finally, alternatively spliced CD44, a cell adhesion
molecule, potentiates tumor metastasis

(Gunthert et al.,

1991; Rudy et al., 1993).
Sex-specific alternative splicing of several genes plays
a pivotal role in Drosophila somatic sex determination (Fig
9), These genes are Sex-lethal

(Sxl), transformer (tra),

and double sex (dxs). First, Sxl protein autoregulates its
own splicing. In female flies, Sxl protein blocks the usage
of the 3' splice site of intron 2 of Sxl pre-mRNA. This
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Figure 9. Alternative splicing in Drosophila somatic cell
sex determination. The exon-intron organizations and the
splicing pathways of Sxl, tra, and dsx are diagramed in
the middle. The female-specific pathway depicted at the
top, while the default pathway at the bottom. The products
of the female-specific splicing pathways are diagramed on
the left and those of the default splicing on the right.
Sxl: sex lethal; tra: transformer; tra2: transformer 2;
dsx: double sex. Open box with number: exon; solid line:
intron. At the bottom, female form of dsx protein
represses the functions of the male differentiation genes,
while the male form dsx protein represses the functions of
the female differentiation genes.
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leads to the splicing of exon 2 onto exon 4, resulting in
Sxl mRNA with exon 3 skipped. In the male flies, exon 3 is
retained by default and no functional Sxl protein is
produced because there is a stop codon in exon 3 (Fig. 9).
The alternative splicing of tra is also regulated by Sxl
protein in a similar way and functional Tra protein is only
produced in female flies (Fig. 9). Tra, along with the
product of transformer 2 (tra2) gene, in turn regulates the
alternative splicing of dsx. Unlike Sxl and tra, dsx encodes
two forms of proteins. The female form is required to
supress male differentiation in the female flies, while the
male form is required to supress female differentiation in
the male flies

(Fig. 9). These two forms are generated by

alternative splicing of its pre-mRNA by using alternative 3'
splice sites. Tra and Tra2 proteins activate the femalespecific splicing of dsx pre-mRNA by forming a protein
complex on a splicing enhancer located 300 bp downstream of
the female-specific 3' splice site (Tian and Maniatis,
1993).
A well studied pre-mRNA alternative splicing in mammalian
cells is the splicing of human immunodeficiency virus type 1
(HIV-1) precursor RNA. In HIV infected cells, the fulllength 9-kb viral transcript is spliced inefficiently to
yield several classes of mRNAs that include the unspliced 9kb mRNA and singly spliced 4-kb mRNAs (which encode
structural viral proteins), and doubly spliced 2-kb mRNAs.
The 9-kb and the 4-kb mRNAs contain functional introns and

splice sites, and their appearance in the cytoplasm is
absolutely denpendent on the viral trans-activator Rev
protein (Chang and Sharp,

1989}. Without Rev protein, the

expression of the structural viral proteins
virus proliferation)

(and hence the

is inhibited. Rev mediates its function

through a cis-acting RNA sequence termed Rev-responsive
element

(RRE), which is located in the env gene of HIV-1 and

in the unspliced intron of the 9-kb and 4-kb class mRNAs.
Until recently, it is not clear whether Rev-mediated
cytoplasmic expression of the unspliced, RRE-containing RNA
is due to the inhibition by Rev of the splicing of RREcontaining intron, or due to the Rev-facilitated export of
RRE-containg RNA, or both. Using an in v'itro splicing
system, Kjem et al.

(1991) tested whether Rev inhibits pre-

mRNA splicing. These researchers found that Rev inhibits
pre-mRNA splicing in an RRE dependent manner. On the other
hand, the splicing of RRE-containing pre-mRNA is not
inhibited with the absence of Rev protein. Further more,
Kjem and Sharp (1993) have showed that Rev inhibits RREcontaining RNA splicing by blocking the entry of U4/U6/U5
tri-snRNP during spliceosome assmbly. On the other hand,
Fisher et al.

(1994) have demonstrated that Rev directly

promotes the nuclear export of unspliced RNA, Therefore, Rev
functions by both inhibiting the splicing and the export to
cytoplasm of RRE-containing, unspliced or singly spliced HIV
RNAs.
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Several mammalian SR proteins have been shown to regulate
pre-mRNA alternative splicing. ASF/SF2 and SC35 promote the
use of the proximal 5' splice site among two competing
alternative 5' splice sites, while SRp40, SRp55, and SRp70
promote the use of the distal 5' splice site in vitro (Zuo
and Manley, 1993; Ge and Manley,

1990; Ge et al., 1991;

Krainer et a l ., 1990; Mayeda and Krainer 1992; Mayeda et
al., 1992, 1993;

Fu et al., 1992; Zahler et al., 1993). The

RS domain of ASF/SF2 was found essential for its splicing
factor activity but not for splice site switching (Zuo and
Manley,

1993). ASF/SF2 and SC35 also favor the proximal site

in a pre-mRNA containing duplicated 3' splice sites

(Fu et

al., 1992).
In addition to SR proteins, another cellular RNA binding
protein, the heterogeneous nuclear ribonucleoprotein Al
(hnRNP Al), has also been found to regulate pre-mRNA
alternative splicing. This protein promotes the use of the
distal 5' splice site, which is antagonistic to ASF/SF2
(Mayeda and Krainer,

MULTIPLE

PROMOTERS

1992).

OP

PROTEIN

ENCODING

GENES

The two rmPFK cDNAs (Li et a l ., 1990) could be produced
by two seperate promoters. Therefore, studies on multiple
promoters of eukaryotic genes are reviewed here.
Most mammalian genes encoding proteins are transcribed
from one promoter. However, an increasing number of genes
have been reported to have more than one promoter
review, see Schibler and Sierra,

(for

1987). For example, the
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gene encoding the 6-phosphofructo-2-kinase/Fructose-2, 6 bisphosphotase

(6PF-2-K/F-2, 6-BPase) is transcribed by two

tissue-specific alternative promoters: a downstream promoter
transcribes the gene in the liver, while an upstream
promoter expresses the gene in the muscle (Darville et al.,
1989). F-6-P-2-K/F-2, 6-BPase catalyzes the synthesis and
degradation of F-2, 6-BP, a very potent activator of
mammalian PFK. Human aldolase A gene, whose product is also
involved in glycolysis, is transcribed by three alternative
promoters

(Gautron et al.,

1991). Mouse y-glutamyl-

transferase gene expresses its six mRNAs from five
promoters, three of which are kidney specific

(Rajagopalan

et al., 1993; Sepulveda et al., 1994). The human carbonic
anhydrase I gene contains two promoters with different
tissue specificities

(Brady et al., 1991). Multiple promoter

usage has also been observed in mouse glucocorticoid
receptor gene

(Strahle et al., 1992), rat dopamine-D2-

receptor gene

(Valdenaire et al., 1994), and rat liver

alkaline phosphatase gene

(Toh et al., 1989).

What is the advantage of having multiple promoters for a
gene? In transcribing a single gene from multiple promoters,
an organism gains additional flexibility in controlling the
expression of the gene. In higher eukaryotes, multiple
promoters are usually associated with tissue- and/or
developmental stage-specific expression of the genes. As
mentioned above,

functional Sxl protein is required to

regulate the alternative splicing of its own and tra
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pre-mRNA splicing and to produce functional Sxl and Tra
proteins only in female flies. Then, where does the initial
functional Sxl protein come from in the female but not in
the male flies? Keyes et al.

(1992) showed that the Sxl gene

actually has two promoters, Pe (for embryonic or
establishment promoter) and Pm (for maintenance promoter).
Pe is located within the intron of the Sxl-Pm transcription
unit (Keyes et al., 1992). Pe is active in early embryos of
the 2X/2A female but not in those of the 1X/2A male flies.
In addition, the transcripts produced from Pe are spliced
directly from the embryonic exon 1 to exon 4, skipping exons
2 and 3 (exon 3 has a stop codon, Fig, 9). Except the Nterminal 25 aminal acids, the early transcripts encode
proteins identical to the late female transcripts. These
embryonic Sxl proteins direct the female-specific splicing
of the first transcripts expressed from the late, Sxl
maintenance promoter

(Estes et al. 1995).

There are several mechanisms that may have produced a
gene with multiple promoters during evolution. First, a gene
may acquire a second promoter via transposable elements or
retroviral integration. For example, promoter insertion via
retroviral integration has been shown to be responsible for
the activation of cellular oncogenes (Hayward et al, 1981).
Second, an additional promoter may be created by inversion
of DNA sequence. It has been shown that the Antennapedia
{Antp) phenotype (conversion of antennae into legs) in
Drosophila resulted from a promoter insertion via inversion
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(Fisher et al., 1986). Upstream of Antp (locus 84B) there is
a transcription unit belonging to locus 84C, which is active
in the head. Structural analysis of the mutant allele of
Antp revealed an inversion of a DNA stretch of the 84C
promoter. As a consequence, Antp transcription is brought
under control of the head-specific 84C promoter, leading to
Antp expression in the head. Another way to create tandem
promoters may be the duplication of a promoter followed by
diversification. Such example has been reported for the gene
encoding pancratic amylase in mouse strain CE (Bodary et
al., 1985). Finally, multiple promoters may also be created
by deletion. For example,

in Drosophila melanogaster, the

ADH gene contains a single gene with two promoters. In D.
muelleri, however, there are two functional ADH genes in
tandem, each with one promoter (Fischer and Maniatis,

1986).

The D. melanogaster ADH gene and its two promoters may be
produced by the deletion of the coding region of the
upstream gene.
Having multiple promoters is sometimes not conserved
among different species. For example, the human aldolase A
gene has three promoters. However, there is no mouse
counterpart for the most upstream promoter of the human
gene, although homology exists in the coding regions for the
human and mouse genes (Stauffer et a l ., 1990; Gautron et
al., 1991). In rat, the aldolase A gene also lacks the most
upstream promoter (Mukai et a l ., 1991). The most upstream
promoter of the human gene may be acquired in human or
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deleted in mouse and rat after humans and rodents
diversified.
The regulation of a gene is more complex when the gene
has multiple promoters. One aspect of this complexity is
that the multiple promoters share an enhancer.

In other

words, the same enhancer activates the transcription from
more than one promoters. For example, the most upstream,
constitutive promoter of the human aldolase A gene shares a
muscle-specifc enhancer with the muscle-specific promoter in
the muscle cells, but shares a ubiquitous enhancer with the
most downstream, constitutive promoter in other cells
(Concordet et al., 1993). On the other hand, having multiple
promoters might result in one promoter interfering with the
expression of the other promoter(s). The Drosophila
melanogaster ADH gene is such an example. As mentioned
above, this gene has two promoters. The proximal promoter
transcribes the gene primarily in first to early thirdinstar larvae, while the upstream promoter is active in late
third-instar larvae and adults (Corbin and Maniatis,

1989).

Each promoter has its own enhancer, but the ADH larvae
enhancer and the proximal promoter are seperated by the ADH
adult enhancer and the distal promoter. When the distal
promoter is active, the proximal promoter is shut off. If
the distal promoter is deleted, the proximal promoter is
active in first instar larvae to adults. Therefore, the
developmental switch from the proximal to distal promoter is
regulated by the stage-specific activation of the distal
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promoter, and the subsequent repression of the proximal
promoter by transcriptional interference
Maniatis,

(Corbin and

1989).

Another example of promoter switch during development is
the human fetal (y-)-to-adult (fl-> globin gene swtich. I
include this mammalian example here, although the two
promoters transcribe not the same, but two closely linked
genes. When either the human y- or fi-globin gene is linked
seperately to the (5-globin gene locus activation region
(LAR), both genes ca be expressed in transgenic mice
throughout development. However, when both genes are linked
to the same LAR, the normal developmental switch of the
human globin gene expression is reproduced in the transgenic
mice (Enver et al., 1990), Therefore, the human fetal-toadult globin switch is controlled through a mutually
exclusive interaction between LAR and either the y- or (1globin gene, resulting in the expression of only one of
these two gene at any given moment (Enver et al., 1990).
Although the detailed mechanism of this mutually exclusive
expression of only one of these globin genes is not clear,
several adult stage-specifc transcription factors (NF-E4 and
bCTF) have been shown to interact with the promoter region
of the adult gene to subsequently activate this gene and
indirectly repress the expression of the fetal globin gene
(Foley and Engel,

1 9 9 2 ) . Another factor is human Erythroid

Kruppel-like factor (EKLF), containing zinc finger domains
similar to the Kruppel protein of Drosophila melanogaster.
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This protein has been shown to bind to the CACCC element in
human (J-globin gene promoter and activate the transcription
of the (5-globin gene ( D o m e et a l ., 1995) . This factor
activates the adult gene 1000 -fold, while it activates the
fetal gene only 3-fold. This is because the EKLF protein
binds to the CACCC box of the adult gene 8 -fold more
efficiently than to that of the fetal gene. In addition,
this factor is expressed at a 3-fold higher level in adult
erythroid tissue than in fetal erythroid tissue (Donze et
a l ., 1995) .

OBJECTIVES

AND

RATIONALE

In this dissertation research,

I have set forth three

objectives:

The first object! vs
characterise the 5'
rnFFK g e n e .

of this study is to
ends of the mRNAs of the

The rabbit muscle PFK gene (Lee et al,, 1987) and then
its two cDNAs (Li et al., 1990) were previously cloned. Yet,
whether the two cDNAs are derived from two separate
promoters or from one promoter and alternative splicing
remains elusive. To further study the regulation of this
gene, it is important to characterize the 5'-ends of its
mRNAs and the transcription start sites.
Three methods will be used to accomplish this goal:

(1)

anchored polymerase chain reaction (PCR) to directly clone
and sequence the 5'-end of the rmPFK mRNA;
extension;

(3) SI mapping.

(2) primer
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There are advantages and drawbacks for each method. In
primer extension and anchored PCR, secondary structure in
the RNA template might cause reverse transcription to be
prematurely terminated. In this case, the end of the cDNA
extended from the primer would be shorter than the actual 5'
end of the mRNA, SI mapping and RNase protection assays are
similar in principle: a labeled DNA or RNA probe is
hybridized to the mRNA, and the 3' overhang of the probe is
digested by SI nuclease or RNase, while the double stranded
mRNA-probe is protected from SI or RNase digestion. The size
of the protected probe will indicate the 5'-end of the mRNA
that hybridized to the probe. However, if there is an intron
spliced out in the mRNA but not in the probe, the splicing
junction instead of the 5' end of the mRNA will be mapped.
Since there are intrinsic problems with each method,
combinations of two or three of the methods will be used to
map the 5' end of the mRNA.

Tho second objectivo is to etudy the tiseue•pecificities of the different rmPVK mRNAa.
As mentioned above, the rabbit muscle PFK is highly
expressed at the protein level in skeletal muscle, brain,
heart, kidney, but at very low levels in liver. Since there
are at least two rmPFK mRNAs, it is important to understand
the tissue-specificities of different rmPFK mRNAs. Northern
blot analysis and reverse-transcription

(RT)-PCR wil1 be

employed to accomplish this objective. Both methods are
frequently used in studying gene expression at the mRNA
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level. The sensitivity of the latter method is higher than
that of the former. In addition, the RT-PCR will detect
alternatively spliced mRNAs.

The third objective is to optiaise conditions
priaer extension using s theraostable DMA
polyaerase.
During the course of the study,

for

I found that the

secondary structure in the rmPFK mRNAs causes the reverse
transcription to prematurely terminate in primer extension
and anchored PCR. Higher temperatures of the reverse
transcription reaction destabilize the secondary structure
and hence minimize the problem. Conventional reverse
transcriptase,

such as M-MLV reverse transcriptase or AMV

reverse transcriptase, can only tolerate a temperature up to
50°C. At 50°C, the secondary structures in the rmPFK still
cause problems. Meyers and Gelfand (1991) reported that a
94-KDa DNA polymerase from Thermus thermophilus possesses
reverse transcriptase activity at temperatures as high as
75°C. However, the reverse transcription reaction is not
efficient enough for primer extension analysis. I therefore
will optimize the experimental parameters for the reverse
transcription reaction using this thermostable enzyme
(Section II) .
This improved method will be used in the reverse
transcription reactions in the primer extension and anchored
PCR experiments characterizing the rmPFK mRNAs described in
SECTION I of this dissertation.

SECTION I
TISSUE-SPECIFIC EXPRESSION OF SIX TYPES OF RABBIT
MUSCLE PHOSPHOFRUCTOKINASE mRNAS BY MULTIPLE
PROMOTERS AND ALTERNATIVE SPLICING
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INTRODUCTION
Phosphofructokinase (ATP:Fructose-6 -phosphate 1-phosphotranferase, EC 2.7.1.11, PFK) catalyzes the phosphorylation
of fructose 6-phosphate to produce fructose 1 ,6bisphosphate, the rate-limiting step in glycolysis. PFK
controls glycolytic flux through its allosteric responses to
cellular metabolites. For example, mammalian PFK is
inhibited by high concentration of ATP and citrate. On the
other hand, it is activated by ADP, AMP, F-l, 6-BP, and F2, 6-BP (reviewed in Dunaway, 1983; Uyeda,

1979).

in

mammalian tissues, PFK can exist as homo- or heterotetramers of three types of subunits: M (muscle) type, L
(liver) type, and C for a third type of subunit in brain.
For example, in human, rabbit, and rat, the M type PFK is
the predominant isozyme in skeletal muscle, while the L type
is the most abundant form in liver. In heart, brain, and
kidney, PFK exists as homo- or hetero-tetramers of all three
subunits

(Tsai and Kemp, 1973; Dunaway and Kasten, 1987;

Dunaway et a l ., 1988). The homo-tetramers of M, L, and C
type subunits of the rabbit PFK have been shown to possess
different kinetic properties

(Foe and Kemp,

1985) . Among the

three rabbit isozymes, the M PFK is the least sentitive
isozyme to ATP inhibition, while the L PFK is the most
sensitive one. To activation by Pi, AMP, ADP, and F-2,6-BP,
the M isozyme is the most sensitive one, while the C isozyme
is the least sensitive one (Foe and Kemp,

1985). The
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relative levels of these three isozymes in a given tissue
determine the composition of PFK tetramers and subsequently
their allosteric behavior in that tissue (Dunaway and
Kasten,

1987; Dunaway et ai., 1988). Thus the molecular

basis for the regulation of the rate of glycolytic flux lies
in the control of the tissue-specific expression of the
genes encoding the three types of PFK subunits.
To study the regulation of tissue-specific expression of
the mammalian PFK gene, the gene for rabbit muscle PFK was
cloned (Lee et al.,

1987). More recently, two cDNAs of this

gene with different 5* untranslated regions (UTRs) were
cloned. The 5 ’ UTR of one cDNA has an intron spliced out (Li
et al., 1990). In this study, more cDNAs for the 5' UTRs of
the rmPFK gene were cloned using anchored polymerase
chain reaction

(PCR)

(Loh et al., 1989) and reverse

transcription-PCR (RT-PCR)

(Meyers and Gelfand,

1991) . The

cloning results indicate that there are six types of rmPFK
mRNAs that differ in the 5' UTR. These rmPFK mRNAs are shown
to be expressed in tissue-specific manners by at least three
promoters and by alternative splicing. Further the
transcription start sites of two promoters of this gene have
been determined. Altogether, the results of this study
indicate that the rabbit muscle PFK gene expresses its six
mRNAs tissue-specifically by multiple promoters and
alternative splicing.
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MATERIALS
Victors,

AMD

METHODS

bacterial

strains,

and

ansyMas

Restriction endonucleases, DNA ligase, and DNA kinase
were obtained from GIBCO-BRL Co., New England Biolabs, or
Boehringer Mannheim Corp. M-MLV reverse transcriptase
(Superscript) was purchased from GIBCO-BRL Co. Tag and Tth
DNA polymerases were purchased from Perkin Elmer Cetus Corp.
SI nuclease was purchased from Promega. Bluescript II KS( + )
plasmid, helper phage and the XLl-Blue strain of E. coll
were from Stratagene. The Sequenase® kit and terminal
deoxynucleotidy1 transferase were purchased from United
States Biochemical Corp. Nucleotides labeled with 32P or 35S
were obtained from duPont-NEN or ICN Biochemicals.

Oligonuclnotidns

used

in

this

The oligodeoxyribonucleotides
(listed in Table 2) include:
PCR;

study
(oligos) used in this study

(1) primers used in anchored

(2) probes used in Northern blot analysis;

(3) primers

used in RT-PCR studies; and (4) primers used in primer
extension studies. The oligos for the rabbit muscle PFK gene
are named from A to 0. The lowercase x in the name denotes
an Xbal restriction site at the 5' end of the primer. The
oligos were synthesized in house and purified from
polyacrylamide-urea gel

(Sambrook et al., 1989). Oligo(dT)-

cellulose

(Type III) was purchased from Collaborative

Research,

Inc.
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Table 2. Oligonucleotides used in this study

Oligonu
cleotide

Sequence {5*

-- >

3')

Position*

Ax

GATCCACIC2AS&AGGCAAGACGATGGTCAGTTAGG

Bx

G A T C TA G A C C T A A T A C C T T G T G T GGGA

C

GGCTGCATGGTGCTCTTCATGGGTC

+3, M

Cx

G G A TC C TCTA G A G G C T G C A T G G T G C T C T T C A T G G G T C

+3, M

Dx

GGGCTCTAGAGCCCCCCCCCCCCCCC

E

CACCGCGATGGCCTTGCCGACCCCCAGGGT

+31, H

F

AAGGCAAGACGATGGTCAGTTAGGACACA

-41, M

G

GTGTGGGACTTGAACTGCTTCTTATGCAC

-1736, H

H

CTCTGTGGCCTTTCGCAGGAGTCTG

-1973, M

I

GTCCTGCAATCCATGCGTGTGAACA

-2570, M

J

GCCGCGCTCGCCTCAGTCCCAGCTT

-2045, M

K

CTAACTGACCATCGTCTTGCCTT

L

CAGACTCCTGCGAAAGGCCACAGAG

-1949, P

H

gggtctctgttcacacgcatggatt

-2554, P

N

CTGGGAC TGAGGC GAGCGCGGCC TT

-2010, P

0

CTGCCATCACCGCCTATCACACA

-36, H
-1715, M

-13, P

+340, M

GAFDH1

CATGTAGACCATGTAGTGGAGGTCAATG

M

GAPDH2

GATCCATTCATTGACCTCCACTACA

P

GAPDH3

GATCTCGCTCCTGGAAGATGGTGAT

M

The lower case x in the name of the oiligo
represents an Xbal restriction site at the 5* end.
This Xbal restriction site is underlined in the
sequence of primer Ax, Bx, Cx, or Dx. Oligo C and Cx
are essentially the same, except that Cx has an Xbal
site at the 5* end.
*: The number is the position of the nucleotide at
the 3' end of each rmPFK primer or probe relative to
the ATG start codon, with A being +1. P or M
following the position indicates the oligo is
located on the plus or minus strand, respectively.
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Preparation

of

poly(A)+ RHAs

Total RNAs from skeletal muscle, liver, kidney, heart,
and brain of 10 day-old New Zealand white rabbits were
extracted by homogenizing the tissue in guanidinium
isothiocyanate,
centrifugation

followed by cesium chloride gradient
(Chirgwin et al., 1979). Poly(A)+ RNA was

purified from total RNA by oligo(dT) cellulose column
chromatography (Sambrook et al., 1989). The concentration of
poly(A)+ RNA was determined by measuring the absorbance at
260 nm (A260) •

Anehorod

PCR

Anchored PCR (Fig. 10) was performed
al., 1989) with the modifications given

as described

(Loh et

below.

Reverse transcription
Poly (A)+ RNA (8 )lg) was co-precipitated with 25 ng of
primer C or E (Fig. 10), dissolved in 20 )il of buffer

(80 mM

Tris, pH 8.3; 80 mM KC1), heated at 90°C for 2 min., and
allowed to anneal at 52°C for 3 hr. After annealing, 30 ^.1
of reverse transcription mixture
bovine serum albumin

(20 mM

[8 SA]; 0.5 mM each

DTT; 0.1 mg/ml
of dATP, dGTF, dCTP,

and dTTP; and 20 units of RNAsin [Promega]) was added to the
annealing mixture. Reverse transcription was carried out in
the presence of 0.03 ^Ci of [a-35S]dATP and 200 units of MMLV reverse transcriptase
1 hr.

(Ausubel et al., 1993) at 42°C for
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Figure 10. Strategy of anchored PCR used to clone the 5*
UTRs of different rmPFK mRNAs. ( A ) Schematic of the genomic
DNA contains the 5' flanking region and the first coding
exon of the rmPFK gene. (B) Diagram depicting the scheme of
anchored PCR to clone the 5 ’ portion of rmPFK cDNAs that
contain the 5' UTRs of cDNA-A and cDNA-B (Li et al., 1990).
Primer C was annealed to rabbit poly(A) RNA and extended
with reverse transcriptase. The cDNAs were tailed with dGs
with terminal deoxynucleotidyl transferase. The tailed
cDNAs were amplified with primer Ax or Bx and Dx. Primers
Ax and Bx are specific to the 5* UTRs of cDNA-A and cDNA-B,
respectively. Primer Dx is an oligo with 15 consecutive dCs
and a Xbal restriction site at the 5'. The sequences of the
primers are shown in Table 2. Arrows: primers used in
anchored PCR; X: Xbal restriction sit; open box: 5* UTR of
cDNA-A or cDNA-B; dotted box: the first coding exon. (C)
Anchored PCR strategy used to clone the 5' UTRs of
different kinds of mRNAs transcribed by all the alternative
promoters of the rmPFK gene. In this experiment, reverse
transcription was carried out using primer E and rabbit
muscle poly(A) RNA. The oligo dG tailed cDNA products were
applified with primers Cx and Dx. Primer Cx is primer C
with a Xbal site at the 5* end. Open box with broken end;
5' UTR of all kinds mRNAs of the rmPFK gene.

TATA

J_

B

ssr
I

cDNA-B

Dx

1 cONA-A

c

«

any rmPFK
mRNA
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Tailing the 3* ends of cDNAs with dGs hv terminal
deoxynucleotidvl transferase
The unincorparated deoxynucleoside triphosphates
remaining from the previous step were removed
using a Sephadex G-50 column (5 Prime to 3 Prime Co.).
Fractions included in the first radioactive
peak were pooled and precipitated with 2.5 volumes
of ethanol in the presence of 0.3 M sodium acetate.
The purified DNA-RNA duplex was dissolved in the tailing
buffer

(0.1 M sodium cacodylate, pH 7.1; 2 mM MnCl 2 ; 0.1 mM

DTT; 80 *iM dGTP; 0.05 mg/ml BSA)

(Deng and Wu, 1983). The

dGTP polymerization reaction was carried out by the
addition of 34 units of terminal deoxynucleotidyl
transferase and incubation at 30°C for 1 hr.
The products were precipitated once with ethanol
and redissolved in 20 )il of TE (10 mm Tris, pH 7.6;
1 mm EDTA).
PCR amplification
One third of the DNA products generated from the tailing
process was amplified by PCR (Saiki et al.,

1988) using an

rmPFK specific primer and primer Dx containing 15 C's and a
Xbal site at the 5' end (Fig. 10; for sequence see Table 2).
The conditions for denaturation, annealing and
polymerization were 95, 55 and 72°C for 1.5, 1 and 2 min,
respectively. The amplifications were carried out for 30
cycles.
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Cloning and sequencing of the PCR products
These PCR products were inserted into the Xbal site of
Bluescript plasmid which was subsequently transformed into
the XLl-Blue strain of E, coli. Single-stranded DNA
templates were prepared by coinfecting the cells with VCSM13 helper phage according to the manufacturer's
instructions. DNAs were sequenced by the dideoxynucleotide
chain termination method (Sanger et a l ., 1977) using
Sequenase kit (USB).
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mapping
SI mapping was carried out as described (Ausubel et al.,

1993). Briefly, the 5' labeled oligo F or G (Table 2) was
annealed to the single-stranded DNA of plasmid RMPFK5', This
plasmid was constructed by inserting the 5' flanking region
of the rmPFK gene into the SstI site of pBluescript vector.
The annealed oligo was extendede using Sequenase (USB). The
single stranded probes were purified from an alkaline
agarose gel. 2X10 5 CPM (0.2 pmole) of each probe was
hybridized with 8 Jig poly (A)+ RNA in the aqueous
hybridization buffer overnight at 50°C. SI nuclease

(150

units per 300 jjtl reaction) digestion was carried out at 30°C
for 1 hr. Final products were analyzed on a sequencing gel.
The size marker is the sequencing ladder using oligo F or G
as primer, and plasmid RMPFK5' as template, both of which
are used to generate the single-stranded SI mapping probe.
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Frinwr

extension

Primer extension was performed as described (Ausubel et
a l ., 1993) with 8 Jig poly (A) + RNA from rabbit muscle and
2xl0 5 CPM (0.2 pmole) of 5' end labeled primer. Reaction
products were resolved on 6 % polyacrylamide gels containing
8 M urea.

Primer extension and
Tth DNA Polymerase

anchored

PCR

using

thermostable

Primer extension by Tth DNA polymerase was carried
out as described below. The hybridization mixture
(12 u D

containing 16.7 mM Tris-HCl

(pH 8.3),

150 mM KC1, 2xl0 5 CPM (0.2 pmole) of primer B and
8 (ig of rabbit poly(A)+ RNA was heated at 75°C for

5 minutes to denature the RNA. After annealing at 65°C
for 5 minutes, extension mixture (8 111) containing
2.5 mM Mnci2, 500 JIM each of dATP, dGTP, dCTP, and dTTP,
and 5 units of Tth DNA polymerase was added to
the hybridization mixture. 20 (11 of mineral oil was
overlaid on top of the reaction mixture. Primer extension
was carried out at 65°C for 1 hour. All the incubations
were carried out in a Perkin Elmer Cetus thermocycler.
After the extension, the mineral oil was carefully removed
and residual oil was further depleted by phenol/chloroform
extract ion.
Along with 20 (ll of H2O, 105 (11 of RNase reaction mixture
(100 (ig/ml salmon sperm DNA, 20 (ig/ml DNase-free RNase A,
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Ausubel et al., 1993) were added to each of the primer
extension reaction tubes. RNase digestion was carried
out at 37°C for 15 minutes. The mixture was extracted with
phenol/chloroform/isoamyl alcohol and precipitated and
analyzed as described (Ausubel et al., 1993)
Anchored PCR using Tth DNA polymerase was carried out as
described above using Superscript reverse transcriptase,
except that Tth DNA polymerase instead of the Superscript
reverse transcriptase was used during the reverse
transcription step.

northern

blot

hybridisation

Northern blot hybridization was carried out as described
(Sambrook et al., 1989). Briefly, 8 jig of poly(A)+ RNA from
each rabbit tissue was fractionated on a formaldehyde
denaturing agarose gel (1%) with 1 X MOPS buffer (20 mM
MOPS, pH 7,0; 8 mM NaOAc; 1 mM EDTA). The RNAs were blotted
overnight onto Nytran membrane (0.45 Jim) . Oligonucleotide
probes were end-labeled using T4 polynucleotide kinase and
[y-3JP]ATP

(Sambrook et al., 1989). Filters were

prehybridized in hybridization solution (6 X SSPE; 10 X
Denhardt's; 50 Jig/ml tRNA; 0.1% SDS; 0.05% NP-40) at 55°C
for 2 hrs and for an additional 20-22 hrs after adding endlabeled probes

<2 X 106 CPM/ml, 10 6 CPM/pmole). Hybridization

was carried out in an Autoblot Micro Hybridization Oven
(Bellco Glass).
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Analysis of tbs six rsFTK mRNA
tissuss by RT-PCR tschniqus

sxprsssion

in

rabbit

rt-PCR was performed as described (Meyers and Gelfand,
1991), except that the reverse transcription reaction was
carried out at 65°C for 10 min instead of at 70°C for 5 min.

RESULTS
Cloning and aaquancing of cDNAs for tbs
tbs rmPTK mRNAs by ancborsd PCR
Li et ai.

5'

UTRs

of

(1990) previously cloned two cDNAs of the

rmPFK gene with divergent 5' UTRs but with identical coding
regions. Alignment of the sequences of these 5' UTRs with
the 5' flanking genomic sequence of the rmPFK gene
revealed that cDNA-A has a 1.69 kb intron removed by
splicing in the 5' UTR (Fig. 10B; Li et al., 1990).
Theoretically, cDNA-A and cDNA-B could be derived from two
different promoters or from one promoter by alternative
splicing. If they result from alternative splicing, the
mRNAs should share a common 5' exon. In order to clone
and sequence the 5' exons of the rmPFK mRNAs, anchored PCR
(Loh et al., 1989) was used.
The anchored PCR is described in detail in MATERIALS

AND METHODS and outlined in Fig. 10 in this SECTION. When
primer Ax

(Fig. 10B) was used, six clones were sequenced.

Among them, three clones are identical and are therefore
interpreted as one cDNA (designated as cDNA-1). The sequence
of this cDNA is shown in Figure 11. The 5' end of this cDNA
is located at -86 (The A of the ATG translation initiation
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cD N A -1

AGTCTGACGAAGCTGTCGCTTGAGCTAGCGGCACCTTGACCCAGCTGTGTCCTAACTGACCATCG
TCTTGCCTTCTAGAGTGGATCATaACCCATGAAGAGCACCATGCAGCC- 3 '

cD N A -2

AATCTAGTCCAAACCCTTCTTAGTGCATAAGAAGCAGTTCAAGTCCCACACAAGGTATTAG|AGT
GGATGAXQACCCATGAAGAGCACCATGCAGCC- 3■

cD N A -3

GAGAGCGGGGAGAAGCTGGGACTGAGGCGAGCGCGGCCTTCG|CTCTCCGGAGGTATAAAACGTG
AGAGGGGCAGGCTGCTGAC CCCCAATCTAGTCCAAACCCTT CTTAGT GCATAAGAAGCAGTTCAA
GTCCCACACAAGGTATTAG|AGTGGATCATGACCCATGAAGAGCACCATGCAGCC- 3 ’

cD N A -4

GAGAGCGGGGAGAAGCTGGGACTGAGGCGAGCGCGGCCTTCG|AGTGGATCATQACCCATGAAGA
GCACCATGCAGCC- 3 •

c D N A -5

TGCCAGCTTTTAGTAGCCCTCCCGTCCTCGGGGTCATCTGTCCAGTGGTCGGCAGACTCCTGCGA
aaggccacagagcaagtgtgtgaggctttgtggggtggacgatctcttgcagtacctgttctgcc

GCCGTAGCACAGCGCAGCCATGAATCCTGTGTGAATGGAGGTGTAAGGATGGTCTCTGAATCTGA
a tttcc tctg ttc ttca cc tg tc a c a g ctctccg g a g g ta taa aacgtgagaggggcaggctgct

GAC CCCCAATCTAGTCCAAACCCTTCTTAGTGCATAAGAAGCAGTTCAAGTCCCACACAAGGTAT
TAG|AGTGGATCATOACCCATGAAGAGCACCATGCAGCC-3>

eO N A -6

GOGCACATGCGTGGGTCTCTGTTCACAOGCATGGATTGCAGGACCTGTGTTTATCCGCATGT|CT
CTCCGGAGGZAIUUCGTGAGAGGGGCAGGCTGCTGACCCCCAATCTAGTCCAAACCCTTCTTA
GTGCATAAGAAGCAGTTCAAGTCCCACACAAGGTATTAG-3 ’

cD N A -7

GCAGACTCCTGCGAAAGGCCACAGAGCAA|CTCTCCGGAGGTATAAAACGTGAGAGGGGCAGGCT
GCTGACCCCCAATCTAGTCCAAACCCTTCTTAGTGCATAAGAAGCAGTTCAAGTCCCACACAAGG
TATTAG|AGTGGATCATQACCCATGAAGAGCACCATGCAGCC-3 ’

Figure 11. Sequences of rmPFK cDNAs cloned by anchored PCR
and RT-PCR. The ATG tranlational start codon is in bold.
The TATAAAA sequence is underlined. Proposed splice
junctions are indicated by vertical lines.
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codon is designated as +1). This cDNA is diagramed in Fig.
12. The 5' ends of the other three clones (sequence not
shown) are 10 bp or less downstream of cDNA-1. With primer
Bx, six clones were sequenced. Among them, five clones are
identical in sequence and are also considered as one cDNA
(designated cDNA-2, Fig. 11 for sequence). The 5' end of
cDNA-2 is located at -1758. The sixth clone is 5 bp shorter
than cDNA-2

(not shown). The 5' end of cDNA-2 is 45 bp

shorter than that of cDNA-A of Li et al.

(1990). SI mapping

results (described later, Fig. 17) indicate that cDNA-2
resulted from premature termination of the reverse
transcription, probably due to a strong secondary structure
in the rmPFK mRNA template. Using a thermostable reverse
transcriptase, several cDNAs containing the entire 5' UTR of
cDNA-2 were cloned (see below). Therefore, cDNA-2 is not
considered a full length cDNA of a rmPFK mRNA and is hence
not diagramed in Fig. 12.
In order to identify other possible rmPFK mRNA whose 5*
UTR is not complementary to either primers Ax or Bx, a
different strategy was utilized (Fig. 10C). Primer E, which
is downstream of primer C, was used to perform the reverse
transcription. The dG-tailed cDNA products were then
amplified by PCR using primer Cx and primer Dx. Primer Cx is
complementary to the first 9 codons of the rmPFK open
reading frame, while primer Dx is an oligo of 15 dCs with a
Xbal site

(Fig. 10C). In theory, any mRNA containing the
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Figure 12. Schematic diagram depicting the organization of
the S' portion of the rmPFK gene and the six mRNAs
identified by anchored PCR and RT-PCR . (A).organization of
the rmPFK gene. Boxes numbered IA, IB, IC, ID, and IE
represents the exons in the 5' UTRs of the gene. Exon I is
the first coding exon. There is no splicing event between
exon IA and exon II. Only shown are the exons in the 5' UTR
and the first 5 coding exons. Bent arrows indicate
transcription start sites. Only start sites a and b have
been established. The bent arrow in front of exon ID and IE
are putative promoters, their transcription start sites
have not been mapped. The positions of the oligo probes
used in the Northern blot are shown under each exon. The
sequences of these probes are shown in Table 2. TATA: the
TATAAAA sequence found in cDNA-A (Fig. 10; Li et al.,
1990); ATG: initiation codon. <B) Schematic diagram
depicting the six cDNAs identified by either anchored PCR
(cDNA-1, -3, -4, -5, and - 6 ) or RT-PCR (cDNA-7), Downward
bent solid line: intron with known sequence. The primers
used in the RT-PCR experiments are shown on top or below
the cDNA. Oligo 0 represents the 3' primer and is
complementary to the fifth coding exon. The sequences of
the primers are shown in Table 2.
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first coding exon of the rmPFK gene should be cloned by this
strategy. Sequence analysis of eighteen clones containing
anchored PCR products
cDNA-1 and cDNA-2

(not shown) confirmed the 5' UTRs of

(Figure 11) cloned using Oligo Ax or Bx as

downstream primer and Dx as upstream primer. These results
also showed the splicing of exon IB onto exon I as in cDNA-A
of Li et a l . (1990).
In addition, two cDNAs with unique 5' UTRs were
identified. The first one is designated cDNA-3 (Fig. 11),
which has an extra 5' exon (exon IE) spliced onto the 5' end
of exon IB (diagramed in Fig. 12). Comparison between the
sequence of this cDNA and the genomic sequence of the rmPFK
gene indicates that another intron of 1011 bp is removed by
splicing in the 5' UTR of this cDNA, in addition to the
spliced intron in cDNA-A of Li et a l , (1990). The second
clone

(cDNA-4, see Fig. 11 for sequence and Fig. 12 for

diagram)

is a splicing variant of cDNA-3; exon IB is not

retained in cDNA-4

(Fig, 12).

Cloning of cDNAs for the 5' UTRs of raPFK mRNAs by
anchored PCR using thermostable reverse
transcriptase rTth DMA polymerase
In an effort to determine the transcription start sites
of this gene, SI mapping results (described later in this
section, Fig. 17) suggest that the 5' end of cDNA-2 results
from premature termination of reverse transcript ion during
the anchored PCR, This premature termination is probably due
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to a strong secondary structure in the 5' portion of rmPFK
mRNA (Fig. 17). Therefore, anchored PCR experiments were
carried out using thermostable Tth DNA polymerase in the
reverse transcription step at high temperature (65°C). The
possible secondary structure in the rmPFK RNA should be
destabilized at 65°C. Using primer C in reverse trancription
and primers Bx and Dx in PCR (Fig. 10B), this experiment
identified three groups of cDNAs that contain exon IB. The
first group (four clones) is designated cDNA-5, with the 5'
end of the longest clone located at -2857 (Fig. 11 for
sequence and 12 for diagram). The second group (one clone)
is a new type (designated cDNA- 6 ), with an exon of 63 bp
(exon ID) spliced to exon IB (Fig, 11). Alignment of the
sequences of exon ID and exon IB with that of the rmPFK
genomic DNA indicates that an intron of 705 bp is removed by
splicing

(Fig. 12), The 5' end of this cDNA is located at

-2591. The third group (eight clones)

is the same as the

afore mentioned cDNA-3 (Figs. 11 and 12). No clone matches
cDNA-2, which is probably derived from prematurely
terminated reverse transcription of the anchored PCR. This
is consistent with the SI mapping results (see later, Fig.
17). Therefore, cDNA-2 is not considered representing a
rmPFK mRNA.
To summarize, these three anchored PCR experiments
identified a total of five rmPFK cDNAs (Figs. 11 and 12),
excluding cDNA-2, An additional cDNA, designated cDNA-7, was
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identified by RT-PCR (see below). The exon sequences of the
5' UTRs of these six rmPFK cDNAs and the genomic sequences
are aligned and shown in Figure 13.

Tissue specific expression of rnPFK mRNAs
contsiningdifferent 5' exons ss analysed by
Northern blot analysis
After the cloning of the cDNAs for the rmPFK mRNAs,
the tissue-specific expression patterns of these mRNAs
were examined by Northern blot analysis using
oligonucleotide probes complementary to the 5' exons
of the rmPFK mRNAs. The positions of the probes are
shown in Figure 12 and their sequences are shown in
Table 2, All the probes detected a single mRNA
aproximately 3 kb in length (Fig. 14). The transcript of
the human muscle PFK gene is also about 3 kb (Sharma et al.,
1990).
The expression of four rmPFK mRNAs are detected by
Northern blot only in skeletal muscle (Fig. 4). Oligo probe
F specific to mRNA-a detected the expression of this mRNA
only in skeletal muscle (Fig. 14). Oligo probe H
complementary to both mRNA-bl and mRNA-b2 detected these
mRNAs also only in skeletal muscle (Fig. 14), Finally,
Northern blot using oligo probe I showed that mRNA-c is also
skeletal muscle specific (Fig. 14),
Using oligo probe J specific to exon IE, the expression
of exon IE was detected in all five tissues examined (Fig.
14). Both mRNA-dl and mRNA-d2 contain exon IE and they are
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Figure 13. Sequences of the 5' flanking region of the rmPFK
gene. The A residue of the ATG (bold phase and underlined)
translational initiation codon is designated +1. Sequences
of exons are in capital letters and underlined. The gap in
the sequence between exon IA and exon I was created to
indicate the boundary of the two exons, so the sequence is
continuous. The TATAAAA sequence found in cDNAs containing
exon IB is italic and in bold face.
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-3017
ttagctc
-3010 actgctcactcattaggcaccccaggctttacactttatgcttccggctcgtatgttgtgtggaattgtg
-2940 agcggataattgtgagcggataacaatttcacacaggaaacagctatgacatgattaegaattegagctc
-2970 <wt«ff^fann^fnaftAWfaMMafiaaflrrflnaarTflaQOCGfcGCGgfSQCCTTCGgggaaeattaocgaQa
Exon IE
-2 900 gctgggaggccgagagcctggagggcggccgt gcggggcgggcgga atcta tagagegcea cagagcggg
-2730 ggccgcgcagagggaeeeecgccgcctccctccttgegtcgcaccgcetcatcctgcggccgggtttggc
-2990 gggaggegetggggccacgtegecceeeaccggcagccaaacctggcccgggcccagtggetccgcaccX
-2590 QCGCACATGCGTGGGTCTCTGTTCAGACGCATGGATTGCAGGACCTGTQTTTATCGQCATGTnfcooat fc.o
Exon ID
-2520 cgggaccggtgtgtgtgcgcatgagtgggtggtgggcecatgtgtgtcctegtgtgtgcatcgctateac
-2450 acacgtgggctgaggcettctgcgtggggtctgcagtgttcgtgcgtcgcgaaatcccgtccggagctcc
-2390 ttgctaggatttctcctccgtgagaacgctgggcttcegeggatgacctccegtcettgggaeaggaacc
-2310 ttgtgattttcctccagcaatgaggagaagaaacggggccggggggtccgagtggtgagatgccttgctc
-2240 ctccctgtttgctccaagtcctcccacttagcttetgcgcgttctctgtgcctttgtggtttgtcactgt
-2170 gcttgcttcggtctcagtgcatttttagaagtggaatgcaaggggtatatctgtgeccaggcctgtttta
-2100 aatttcacctacttgatgtttgetaettgcattgcactttctgtggttatttattggctgtaatgtgcca
-2030 aaaeeTQCCAaCTTTTXGTXGgggTrrrGTCrTCGQOGTrXTfrTftTCCAGTnf.TGGQCAaxnTCCTflCGE
Exon IC
-I960 AAGGCCACAC.Ar^AAyt pt ?ratoyrr tt-yraaapr poanaat ct rt rprior mart pt tctoecaccart
-1990 agcacagcgcagceatgaatcctgtgtgaatggaggtgtaaggatggtctctgaatctgaatttcctctg
-1820 ttct tcieet at e. r.oGTCTCeafiXflfif**a/vsTVjACAfMQGGAGGgTGgTfSACCCfTGXATCTAGT
Exon IB
-1750 CCAAACCCTTCTTAGTGCATAAGAAOrACTTCAAQTCCCXeAeAAGGTATTAr.otg»«toaraactatnt
-1690 ggtcecgttgaatgtatgtcagtgttggtttcccaggecaacaggtgtgtctccagcagtgggtgggggt
-1610 ctgtgegaaggcccagggagccttctggataagagtgcagggcgcctgeaagatgtagggttagagcggg
-1540 aggageaggttgaagccataggacaggtctggatcatggaggctttgcgagcaaccceagcagttgaact
-1470 tgatctgtcagtgctgcttctgtgtggtgtgtgegtgttaactgtgtctcctaatgctatgtgtgtgttg
-1400 tgtgtctcattgeeatgtgtgtggatttgtgtgtcatgtgacctgtatetgagceagtgcetgattgcct
-1330 agatgtgggtggaagcaegaacttccgteagctectgttcatgtgaggtgatgctgtaactggaagctcg
-1260 ggcctgaaecttccagaggctgeactgtgcgeagtgggttaagctgcatatcagaaactgeatccatatc
-1190 tgagtgccagtttgagttctggctgctctgcttgcagtccaetttectgctagtgctcctaggaaggeag
-1120 cagaagatcgccacgtgcttgggeeectactgtgcgtgtggtagaeetgacgcaattcctggctttggct
-1050 gttgtggaeatctggggagagtgaaceagtggatggatgacctetctgtttctctgcttctetcattcce
-980 ccgccaaagtcgctcaaataaataagtgttttttaaaaagagaaagacaggagcccagcaggggagacca
-910 gctgttacagggagcaggtcaggaagacaggcggtgggggggagaagggagttggggaggacggcactgc
-840 agggggtggtggggttggtggcagttttggttctgagagaaagggcggagcaagtgaaaaaeagcaggtg
-770 tttgcctggttgcccggagagtgatgaceccaceagcgttttgagggcaeagaagtetcctgcgctcctt
-700 tgggagaeagcagcaggagtccctgtgteacgtgtgtgcgtgtgtgcatetgtggcagccacctgttgct
-630 tttcacatttagttgtgtgcagtgcgagaggcaggggcaggagggttctgggcctggagctgggaggtac
-560 agggaggtcgaggaatggcccagggcttcctgagectttgaagagtcttggcagtggtgccttcataacc
-490 ccaaactccagcttgaatcccagctctcccgatgetgctaactgtaacgcagcttgtccttgtttttctg
-420 ctttgttggtgcttttggggtccagacctetgactgecaccctgtcacegeccttcgctgagaaggagga
-350 atcttcgaggctcccttgctgtttgctttctgtteagtcatctgcccttcteectgaecttagcttatcc
-280 tgcagatgggttcctctcggggagggagggactagggagggattagccaggacttttgagtcttgggctt
-210 gattactgtggcatttcagcttgtcattccacagggtgtggetcteectggaagaagtccagagttccca
-140 oact oca aage toaoot ogt ggagt qqgagage ct gee ttjagg* qgt»frtit »gggAKTrTGAeGAAGeTCT
-70 CGCTTGAQeTAGCGGCACCTTGACeCAGCTfiTCTeCTAACTGACCATCGTCTTGCCTTCTAG AGTGGATC
Exon IA
1 ATQArrrATRaaf'.aGrarraTGraGrrxr. aacCCTGGGGGTCGGCAAGGCCATCGCGGTGCTCACCTCCG

Exon X
71 GCGGAGATGCCCAAGqtaaqgaqqaqqaqaaeaqqagecatqqctqqtqgecctiqqgttgctigqgtgcct
121 ttgcctgcacactggagetc
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Figure 14. Northern blot analysis of different rmPFK mRNAs.
Poly(A)+ RNAs (8 pg) from different rabbit tissues were run
on a 1% agarose gel with 2.2 M formaldehyde. The nucleic
acids were blotted to Nytran membranes overnight by
capillary force. The blot was hybridized with probes
specific to the exons in the 5' UTRs of the rmPFK gene. The
position of the probes are shown in Fig. 12 and their
sequences are in Table 2. M: muscle; L: liver; K; kidney;
H: heart; B: brain. GAPDH1; hybridized with oligo GAPDH1
(sequence shown in Table 2) complementary to the rabbit
glyceraldehyde 3-phosphate dehydrogenase cDNA (Putney et
ai., 1983). Panels hybridized with probes F , G, and J were
exposed for four days, while those hybridized with probes H
and I were exposed for seven days. All the blots were
hybridized at 55°C for 20-22 hrs and subsequently washed at
55°C two times with IX SSPE and 0.1% SDS and one time with
1XSSPE. With this stringency, signals detected with probe J
are unlikely non-specific (also see Fig. 15D for RT-PCR
results).
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alternative splicing pruducts. Only mRNA-dl is expressed in
all five tissues examined because of the following: Oligo
probe G specific to exon IB, detected rmPFK expression in
skeletal muscle, heart, and brain, but not in liver and
kidney (Fig. 14). Since mRNA-d2 contains this exon,
therefore mRNA-d2 is not expressed in rabbit liver and
kindey tissues. These results and those of RT-PCR (below and
Fig. 15D) indicate that mRNA-d2 is expressed in rabbit
skeletal muscle, heart, and brain, but not in liver and
kidney tissues, where as mRNA-dl is expressed in all five
rabbit tissues examined (Fig, 14 and Fig. 15D). This
indicates that the promoter that produce these two mRNAs is
active in all five tissues, but the alternative splicing is
tissue specific. More specifically, exon IB is retained only
in rabbit skeletal muscle, heart and brain tissues.
A n a l y s i s
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t h a
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The tissue-specific expression patterns of different
rmPFK mRNAs were further examined by RT-PCR. The primers
used in this study are shown in Figure 12 (for sequence, see
Table 2). The common downstream primer (oligo 0) is
complimentary to the fifth coding exon of the rmPFK gene.
The amplified RT-PCR pruducts include the 5 r UTRs and the
five coding exons of the rmPFK mRNAs. The presence of a PCR
product of appropriate size in an agarose gel based upon the
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sequence of the cDNA clones was considered as evidence of
expression.
Results of the RT-PCR analysis are shown in Figure 15.
Oligo K, the upstream primer specific to mRNA-a detected
expression in skeletal muscle and heart tissue (Fig. 15A).
Northern blot analysis detected the expression of this mRNA
only in skeletal muscle (Fig. 14, probe F ) . This discrepancy
might be due to the high sensitivity of RT-PCR compared to
Northern blot analysis. A similar inconsistency has been
found in the studies of human muscle PFK (hmPFK) gene:
although this gene was shown by RT-PCR to be expressed in
all seven human tissues examined,

including skeletal muscle,

liver, and kidney, its expression was not detected by
Northern blot hybridization in liver, placenta, pancreas,
stomach, and reticulocytes (Nakajima et al., 1990).
Oligo L, the upstream primer specific to exon IC showed
that there are two mRNAs expressed in skeletal muscle

(Fig.

15B). The larger one corresponds to mRNA-bl. In addition to
the bl product, a smaller PCR product of the skeletal muscle
RNA was amplified by RT-PCR with primer L (Fig. 15B). This
smaller DNA product

(b2) was gel purified and cloned into

pBluescript II KS(+) vector which was digested with EcoRV
restriction endonuclease (Marchuk et al., 1991). The
sequence of the insert (designated as cDNA-7)

is shown in

Figure 11. Comparison of the sequence of this clone and the
rmPFK genomic sequence indicates that part of the 5' UTR of
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Figure 15. Analysis of the tissue-specific expression of
the six mRNAs of the rmPFK gene by RT-PCR using
thermostable reverse transcriptase Tth DNA polymerase. One
jig of poly (A)* RNA from each rabbit tissue was reverse
transcribed with Tth DNA polymerase using the 3' primer
(oligo
see Fig. 12 for diagram and Table 2 for
sequence). The reverse transcription reaction mixture was
aliquoted into four tubes. Each of the four 5' primers was
then added along with PCR mixture to each tube: Primer K
in ( A ) ; L in < » ) ; M in (C>; and N in ( D ) . The positions of
these primers are shown in Fig. 12B and the sequences are
in Table 2. PCR amplification was performed at 60°C for 1
min and 95°C for 1 min for each cycle. A total of 35 cycles
were carried o u t . The precipitated PCR product were
analyzed on 3% agarose gels (3 parts of Nusieve agarose
from FMC Bioproducts and 1 part of agarose I from Amresco).
For RT-PCR in panel C, the PCR product was diluted 100
times and reamplified for another 35 cycles. The expected
sizes of the RT-PCR products are as following: a: 397 bp;
b l : 64 6 ; c: 526 bp; D 1 : 503 bp; d 2 : 397 bp. The b2 band was
cloned and sequenced and the expected size is 504 bp. (■)
RT-PCR amplification of rabbit GAPDH mRNA using primers
(GAPDH2 and GAPDH3, Table 2) complementary to the rabbit
GAPDH cDNA (Putney et al., 1993). The expected sizes of the
PCR product is 140 bp. M: skeletal muscle; L: liver; K:
kidney; H: heart; B: brain; D: 100 bp DNA size ladder from
GibcoBRL.
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mRNA-bl is removed by splicing as a 142 bp intron (Fig. 12).
Therefore, alternative splicing gives rise to two rmPFK
mRNAs, mRNA-bl and -b2, that contain exon 1C (Fig. 12).
Using oligo M, an upstream primer specific to mRNA-c,
expression of this rmPFK mRNA was detected only in skeletal
muscle

(Fig. 15C). The RT-PCR product in panel C of Figure

15 was reamplified, indicating that mRNA-c is expressed at a
relatively lower level than the other rmPFK mRNAs. This is
consistent with the weak signal detected in the Northern
blot analysis (Fig. 14, oligo probe I),
RT-PCR using oligo N, an upstream primer specific to exon
IE, showed two predominent products corresponding to mRNA-dl
and -d2 (Fig. 15D). As mentioned above, these two mRNAs are
derived from alternative splicing; exon IB is retained in
mRNA-dl but not in mRNA-d2 (Fig. 12). The expression of
mRNA-d2 was detected in all five tissues examined. However,
mRNA-dl was not detected in liver and kidney,

indicating

that exon IB is retained in skeletal muscle, heart, and
brain mRNA, but not in mRNA from kidney and liver (Fig.
15D). These results are consistent with the Northern blot
analyses: rmPFK mRNAs containing exon IE (mRNA-dl and -d2,
Fig. 12) were detected in all five tissues when probe J was
used (Fig. 14). However mRNAs containg exon IB including
mRNA-d2

(Fig. 12) was not detected in liver and kidney

tissues

(Fig. 14, probe G ) .
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The tissue-specific expression patterns of the six rmPFK
mRNAs are summarized and shown in Fig. 12.
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The transcription start site of the proximal promoter
(Pa) that gives rise to mRNA-a was determined by
both primer extension and SI mapping (Fig. 16). The
primer extension study using M-MLV reverse transcriptase
mapped a major site exactly at the 5' end of cDNA-1 and
several minor sites (Fig. 16A). The SI mapping
experiment mapped a major start site in the vicinity of
the major site mapped by primer extension, along
with some minor sites (Fig. 16B), Together, these results
indicate that the proximal promoter of the rmPFK gene
initiates transcription at a major site 66 bp upstream of
the ATG translation initiation codon, specifically at
the A residue in the 5'-GCCAGTCT-3' sequence, along with
several minor sites. No TATA box is found -20 to -30 bp
upstream of these start sites. The sequence surrounding
the major start site (GCCAGTCT) is homologous to the
functional initiator element

(CTCANTCT)

found in the TATA-

less promoter of the murine terminal nucleotidyl transferase
gene (Smale et al,, 1990). Multiple start sites are also
characteristic of many TATA-less promoters

(Dynan, 1986).

For example, the human Ha-ras gene has a TATA-less promoter
and initiates transcription
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Figure 16. Determination of transcription start sites of
the proximal promoter of the rmPFK gene. ( A ) Primer
extension. The primer extension reaction was carried out
with 8 pg of rabbit muscle poly(A)+ RNA. Primer F (panel C
for position and Table 2 for sequence) used in the primer
extension was 5'-end labeled with polynucleotide kinase and
(Y-W P]ATP. (B) SI mapping. Probe A was generated by
annealing the labeled primer F to the single stranded
pRMPFK5'. The primer was extended with Sequenase. The
extended products were subsequently digested with Pstl. The
single stranded probes were subsequently purified with
alkaline agarose gel electrophoresis (Ausubel et al.r
1993). 8 pg of rabbit muscle poly(A)+ RNA and 2x10* CPM of
probe A were hybridized in the aqueous hybridization buffer
overnight at 50°C. SI digestion (150 units/300 pi reaction
mix) was carried out at 30°C for 1 hr. Both the primer
extension product and the SI mapping mixture were analyzed
on a 6 % acrylamide sequencing gel. Size markers are
sequencing ladders generated with primer A and single
stranded DNA of pRMPFKS'. The arrow indicates the position
of the major band in primer extension and SI mapping
analysis. M: muscle.(C) Schematic diagram depicting the
primer used in primer extension and probe used in SI
mapping. The plasmid prmPFK5' was constructed by ligation
of a 2.5 kb Sstl-SstI fragment of the rmPFK gene into the
pBluescript II plasmid. The Sstl-SStI PFK gene fragment
contains 5' flanking region and the first coding exon. The
single stranded SI probe was prepared as described by
Ausubel et al. (1993). Only mRNA-a will hibridize to probe
A. The predicted probe fragment is diagramed under mRNA-a.
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at multiple start sites spead over a 90-base pair region (Lu
et a l ., 1994).
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p r o m o t e r

o f

c l o s e

t r a n s c r i p t i o n
t o

t h a

s t a r t

T A T A A A A

s i t s

of

t h a

s e q u e n c e

Since the 5'-ends of cDNA-2 and -5 are 28 bp downstream
and 233 bp upstream, respectively of the TATAAAA sequence
(Fig, 11), it is possibile that promoter(s)

lie near this

sequence. To determine the transcription start sites
of such promoter(s),

first SI mapping analysis was

performed. A single stranded DNA probe of 680 bp was
prepared with its 5' end located 80 bp downstream of the
TATAAAA sequence
results

(SI probe in Fig. 17E). The SI mapping

(Fig. 17A) showed two groups of protected

fragments. The largest fragment in the first group (bl) at
the top of the gel is about 230 bp upstream of the TATA
sequence. This position is within 5 bp of the 5' end of
cDNA-5 identified by anchored PCR using Tth DNA polymerase.
In the genomic DNA, a TATTTAT sequence is 20 bp upstream
of the S' end of cDNA-5

(5' end of exon IC in Fig. 13).

This sequence is AT rich, but is not a perfect match to
the eukaryotic TATA box consensus sequence [TATA(A/T)A(A/T)]
found 20 to 30 bp upstream of the transcription start
site of many RNA polymerase II promoters
Chambon,

(Breathnach and

1981) .

The other group of fragments (x in Figs. 17A) is about 9
to 14 bp upstream of the TATAAAA sequence. This position
corresponds to a splicing acceptor site (S' end of exon IB),
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Figure 17. Determination of transcription start sites of
the promoter close to the TATAAAA sequence of the rmPFK
gene. ( A ) SI mapping. Probe B (depicted in panel E) was
generated similarly as probe A (see legend to Fig. 11),
except labeled primer G, instead of primer F, was used.
Primer G was extended with Sequenase using the single
stranded pRMPFKS' as template. The extended double stranded
DNA products were subsequently digested with SstI, rather
than PstI restriction enzyme. The single stranded probe was
then isolated from alkaline agarose gel (Ausubel et al.,
1993). 8 pg of rabbit muscle poly(A)+ RNA and 2xl0 5 CPM of
probe B were also hybridized in the aqueous hybridization
buffer overnight at 50°C.
(B)
Primer extension using M-MLV
reverse transcriptase. The primer extension reaction was
carried out with 8 pg of rabbit muscle poly(A)+ RNA and
2xl0 5 CPM of 5' end labeled primer G (panel E for position
and Table 2 for sequence). SI digestion (150 units SI
nuclease/300 pi reaction mix) was carried out at 30°C for 1
hr. The SI mapping mixture were analyzed on a 6% acrylamide
sequencing gel. ( C ) Primer extension using thermostable
reverse transcriptase Tth DNA polymerase. Primer and RNA
used were the same as in (B) (for detail, see Materials and
Methods) Size markers are sequencing ladder using primer B
and single stranded DNA of pRMPFKS'. M: muscle. (D)
Possible secondary structure in the 5' UTR of cDNA-2 as
predicted by the Fold algorithm in the GCG program (Zuker
and Stiegler, 1981; Frier et a l ., 1986). (I) Primer G
(complementary to exon IB) and the SI probe used. The
construction of prmPFKS 1 is described in the legend of Fig.
16. The protected SI probe fragments (bl and x) are
diagramed under individual rmPFK mRNA. mRNA-a and mRNA-d2
are not complementary to this SI probe because they do not
contain exon IB.
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which is 11 bp upstream of the TATAAAA sequence. This
splicing junction is common to mRNA-b2, -c, and -dl

(Fig.

17E) .
The primer extension analysis also revealed multiple
products

(Fig. 17B). The bl band lie about 230 bp upstream

of the TATAAAA sequence, consistent with the SI mapping
results. Therefore, the rmPFK gene likely contains a
promoter that initiates transcription at several sites about
230 bp upstream of the TATAAAA sequence. This promoter is
designated promoter b.
Primer extension generated several products between bl
and y bands in Fig. 17B. These primer extension products may
represent mRNAs such as mRNA-dl, that has extra 5' exons
(exon IE in this case) spliced onto exon IB (Fig. 12). SI
mapping of these mRNAs resulted in protected fragments
corresponding to the 5' end of exon IB, the splicing
junction (x in Fig. 17A). However,

I can not rule out the

posibility that these primer extension products are
artifacts due to the secondary structure in mRNA-bl.
Nevertheless, the size of these products are unlikely
indicative of transcription start sites when compared to the
size marker using genomic DNA sequencing ladder, because SI
analysis did not show bands at the corresponding size.
Finally, primer extension analysis showed there is a
strong band (band y in Fig. 17B) about 28 bp downstream of
the TATAAAA sequence. The 5' end of cDNA-2 identified by

81

anchored PCR using M-MLV reverse transcriptase is also at
this site. However, the SI mapping results (Fig. 17A) showed
that there is no band downstream of the TATAAAA sequence,
particularly 28 bp downstream of the TATA-1 sequence.
To address this discrepancy, primer extension was carried
out at 65°C using a thermostable reverse transcriptase, the
rTth DNA polymerase (Fig. 17C). The results of this primer
extension are similar to that using M-MLV reverse
transcriptase, except that there is

no strong bandabout 28

bp downstream of the TATAAAA sequence (Fig. 17C). This is
consistent with the SI analysis (Fig. 17A) . Therefore,

it is

very unlikely that there is a transcription start site 28 bp
downstream of the TATAAAA sequence.

It is possible that the

y band in the primer extension using M-MLV reverse
transcriptase (Fig. 17B), and the cDNA-2 identified by the
anchored PCR also using M-MLV reverse transcriptase resulted
from the prematurely terminated reverse transcription
reaction. This may be due to possible secondary structure in
the 5' UTR of the mRNA. The fold algorithm in the GCG
program (Zuker and Stiegler,

1981; Freier et al.,

1986)

predicted stem-loop structures in this region (Fig. 17D). In
addition, anchored PCR

using thermostable Tth DNA

polymerase did not identify cDNA-2.

DISCUSSION
Previously, two cDNAs for the rabbit muscle PFK gene has
been cloned (Li et al., 1990). These two cDNAs have an
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identical coding region, but their 5' UTRs are different. In
one of the cDNAs, an intron of 1.7 kb is removed by splicing
(Li et al., 1990). These two cDNAs could be derived from two
promoters, or from one promoter and alternative splicing. In
addition, the tissue specificity of the rmPFK mRNAs have not
been determined.
First in this report, six cDNAs for the 5* UTR and the 5*
portion of the coding region of the rmPFK mRNAs were cloned
(Fig. 12). These cDNAs have the same translation initiation
codon as the full length cDNAs cloned by Li et ai.

(1990).

Thereore, the cDNAs cloned here likely have the same open
reading frame as the full length cDNAs of Li et al.

(1990).

The six cDNAs cloned are consistent with two rmPrK cDNAs
cloned previously (Fig, 10; Li et al., 1990): cDNA-1 in this
study contains the entire 5f UTR of cDNA-A, while cDNA-5,
-7, - 6 , and -3 (from 3' to 5 ’) all contain the entire 5' UTR
of cDNA-2

(Fig. 12 and Fig, 10) and each has more 5'

sequence than the 5' UTR of cDNA-A of Li et al.

(1990).

In addition, cDNA-4 has a 5' UTR that is not present in
either of the two cDNAs of Li et al.

(1990). This cDNA is an

splicing variant of cDNA-3: exon IB (exactly the entire 5'
UTR of cDNA-A of Li et al., 1990) is not retained in cDNA-3.
Two more cDNAs are derived from alternative splicing: cDNA-5
is a splicing variant of cDNA-7; more specifically, the most
5' intron in the 5' UTR of cDNA-5 is retained, but is
removed by splicing in cDNA-7 (Fig. 12). Southern blot
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analysis of rabbit genomic DNA digested with restriction
enzymes indicates that rmPFK is a single copy gene (Knaak
and Chang, unpublished data). The human muscle PFK gene has
also been shown to be single copy (Sharma et a l ., 1990).
The transcription start sites of two downstream promoters
of the rabbit gene have been mapped. Promoter a initiates
transcription at a major site 86 bp upstream of the ATG
translational initiation codon, along with several minor
sites. The 5' end of cDNA-1 identified by anchored PCR is at
the major start site mapped by primer extension and SI
mapping. The transcription start sites of a second promoter
reside at -2025 upstream of the ATG condon. The 5' end of
mRNA-bl is at this site. Although the transcription start
sites of the promoter(s) giving rise to mRNA-c (containing
exon ID), mRNA-dl and -d2 (both containing exon IE) have yet
to be determined. Because exon ID and exon IE are upstream
of promoters a and b, they can not be transcribed from these
promoters and must be transcribed from promoters further
upstream. Therefore, the six rmPFK mRNAs are expressed by at
least three promoters and by alternative splicing from a
single copy gene.
The 5' end of cDNA-2 is 28 bp downstream of the TATAAAA
sequence. Primer extension using M-MLV reverse transcriptase
also showed a band at this position (Fig. 17B) . However, SI
mapping analysis clearly showed no band at this position
(Fig. 17A). Furthermore, primer extension analysis at 65°C

64

using Tth DNA polymerase did not show a band at this
position

(Fig. 17C). Therefore,

it is very unlikely that

there is a transcription start site at this position. The
reverse transcription reaction using M-MLV reverse
transcriptase is probably prematurely terminated at this
position, resulting in a band in the primer extension
analysis and the 5* end of cDNA-2 at this position.
It is intriguing that there is no transcription start
site 20 to 30 bp downstream of this TATAAAA sequence, since
it matches the TATA box consensus sequence found about 25 bp
downstream of transcription start site of many eukaryotic
protein encoding genes (Breathnach and Chambon, 1981) . In
addition, there are multiple putative binding site for
transcription activators upstream of this sequence. For
example, within 200 bp upstream of the TATA sequence there
are three binding sites for the bHLH myogenic transcription
activators, such as MyoD and myogenin (Weintraub et ai.,
1991).
There are several possibilities that there is no
transcription start site downstream of this TATA sequence.
First of all, there may be a specific repression sequence
near the TATA sequence. Second, chromatin structure in this
region might prevent transcription initiation.

It has been

shown in vitro that a minimal promoter containing the TATAbox is able to direct assembly of the transcription
initiation complex onto the DNA template and initiate
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transcription (Buratowski et a l ., 1989). The binding of
transcription factor TFIID to the TATA box is essential for
transcription initiation. However, binding of TFIID to a DNA
template containing a TATA box and subsequently the
transcription initiation is severely inhibited after the
nucleosome assembly

(Workman et al., 1991; Meinsterernst et

al., 1990) .
Recently,

it has been shown human SWI/SNF complex can

facilitate the binding of TATA-binding protein (TBP) to
nucleosomal DNA, but only when the TATA box is in the
favarable position

(Imbalzano et a l . (1994). These

researchers constructed a DNA template of 14 9 bp containing
two nucleosome positioning sequences (Shrade and Crothers,
1989)

at the 5' end and the adenovirus major late promoter

TATA box in the middle (PH MLT). The phasing sequence favors
specific positioning of the histone core. They constructed
two variant templates

[PH MLT9(+3) and PH MLT(+ 6 )]

positioned the TATA box either 3 or 6 bp, respectively,
closer to the phasing sequences. After nucleosome assembly,
TBP can not bind to the TATA box in all three templates.
Human SWI/SNF complex has been shown to facilitate the
binding of TBP to the TATA box in PH MLT (+3) template.
However, the complex does not facilitate the binding of TBP
to the TATA box in the PH MLT and PH M L T (+6 ) templates
(Imbalzano eC a l ., 1994). These data imply that if a TATA
box is not at a favorable rotation relative to the
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nucleosome, even the SWI/SFN proteins can not facilitate the
binding of TBP to the TATA sequence in a DNA template. The
TATA sequence of the rmPFK gene could be in such a position.
There are three sequences near the TATA sequence that match
the consensus nucleosome positioning sequence. For example,
sequence 5'-CCCCCAAT (28 downstream of the TATA sequence)
matches the strong nucleosome positioning consensus sequence
(G/C)3NN(A/T )3 (Shrade and Crothers,
After cloning six rmPFK mRNAs,

1989).

X then studied the tissue-

specific expression of these mRNAs by Northern blot analysis
and RT-PCR technique. The results showed that these mRNAs
are expressed with a complex pattern by both tissue-specific
transcription and alternative splicing: mRNA-bl, -b2, and -c
are skeletal muscle specific (Figs. 14 and 15). The
expression of mRNA-a was detected only in skeletal muscle by
Northern blot analysis

(Fig. 14). However, RT-PCR experiment

showed that this mRNA is also expressed in heart tissue
(Fig. 15A). This discrepancy might be due to the high
sensitivity of RT-PCR compared to Northern blot analysis. A
similar inconsistency has been found in the studies of human
muscle PFK (hmPFK) gene: although this gene was shown by RTPCR to be expressed in all seven human tissues examined,
including skeletal muscle,

liver, and kidney,

its expression

was not detected by Northern blot hybridization in liver,
placenta, pancreas, stomach, and reticulocytes

(Nakajima et

a l ., 1990). The rmPFK mRNA-dl was detected in skeletal
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muscle, heart, and brain tissues, but not in liver
or kidney, while mRNA-d2 was detected in all five
rabbit tissues examined (Fig. 15). The pattern of the
tissue-specific expression of the rmPFK mRNAs
described here is consistent with that of the rmPFK
protein (Table 1; Tsai and Kemp,

1973), The rmPFK has been

shown to be the predominant PFK in rabbit skeletal
muscle. This isozyme has also been shown to be
expressed at the protein level in brain, heart, kidney,
and at very low level in the liver (Tsai and Kemp,

1973).

Mhaskar and Dunaway (1995) studied the subuint
abundance, protein synthesis, and steady state mRNA levels
of the three PFK isozymes during rat neonatal brain
development. Interestingly, from zero to 23 days after
birth, the level of the M-type subunit, the protein
synthesis, and the steady state level of rat muscle
PFK mRNA increased simultaneously, indicating the
steady state level of the M-type PFK mRNA plays an
important role in controlling the abundance of the
muscle type PFK isozyme. This is consistent with the
correlation between the tissue-specific expression
pattern of the rabbit muscle PFK at the protein
leve (Tsai and Kempt, 1973) and at the mRNA level

(this

study).
There are similarities and differencies in the
tissue-specific expression of mutiple mRNAs from the
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rmPFK gene and its human counterpart. The human gene
expresses three mRNAs by two promoters and alternative
splicing (Fig. 7; Yamasaki et al., 1991). The
downstream promoter produces two hmPFK mRNAs, -a and -b.
The hmPFK mRNA-a is a splicing variant of hmPFK mRNA-b:
there is an 89 bp intron spliced out in mRNA-a.
The rmPFK mRNA-a and its human counterpart

(hmPFK mRNA-b)

are highly conserved (80% homology in the 5' UTR). The
upstream sequences of the two genes have diverged
significantly: a 750 bp region of human sequence and its
rabbit counterpart have only 41% homology. The rmPFK
mRNA-a and its human counterparts are both skeletal
muscle specific as examined by Northern blot,
although the rmPFK was detected in the heart by
RT-PCR. The expression of the human counterparts were
not examined in this tissue. The mRNA-c transcribed
by the upstream promoter of the human gene is
probably the counterpart of rmPFK mRNA-d2: both
mRNAs were found expressed in all the tissues examined.
In the hmPFK mRNA-c, the intron in the 5'UTR is
about 3.3 kb, while in rmPFK mRNA-d2, the intron is about
2.8 kb. In the rabbit, there is a splicing variant of this
mRNA, mRNA-dl,

in which exon IB is retained in a tissue

specific manner, more specifically retained in skeletal
muscle, heart, and brain, but not in liver and kidney
tissues

(Fig. 12). There are no cloned human counterparts
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for the rabbit mRNA-bl, -b2, and -c. In mouse, only one
promoter has been characterized for the muscle PFK gene
(Gekakis and Sul, 1994), which is equivalent to the
downstream promoter of the human and rabbit muscle PFK
genes. Such nonconservative usage of alternative promoters
has also been reported in the aldolase A gene. In the human
gene there are three promoters

(Gautron et al., 1991), while

there are only two promoters in the mouse gene, with no
equivalent known human upstream promoter

(Stauffer et al.,

1990).
Multiple mRNAs with different 5' UTRs expressed from
multiple promoters and/or alternative splicing as observed
in rabbit and human muscle PFK genes have also been
reported in other mammalian genes. For example, the gene
from rat encoding a bifunctional enzyme
6-phosphofructo- 2 -kinase/fructose- 2 ,6-bisphosphatase

has two tissue specific promoters, one muscle specific
and the other liver specific (Darville et al., 1989). This
enzyme catalyzes both the synthesis and degradation of
fructose-2, 6-bisphosphate, a potent regulator of PFK (ElMaghrabi et a l ., 1990). The human aldolase A gene contains
three promoters,

including a muscle specific one (Gautron et

al., 1991). Interestingly, aldolase A is also involved in
glycolysis.
The mouse y-glutamyltransferase gene expresses its six
mRNAs from five promoters, three of which are kidney
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specific

(Rajagopalan et ai., 1993; Sepulveda et al., 1994).

The human carbonic anhydrase I gene contains two
promoters with different tissue specificities
(Brady et al., 1991). Multiple promoter usage has also
been observed in mouse glucorticoid receptor gene (Strahle
et al., 1992), rat dopamine-D2-receptor gene (Valdenaire et
al., 1994), and rat liver alkaline phosphatase gene (Toh et
a l ., 1989).
Multiple promoters of these genes may give an
organism more flexibility to fine tune the regulation
of the expression from these genes according to the
physiological function of a given tissue. Multiple
promoters may also serve as a safe guard to prevent
shut-down of the gene expression when key promoter
elements are mutated.

In the case of rabbit PFKs,

all three isozymes are expressed in brain and kidney,
while in skeletal muscle, however, only the M type PFK
is expressed. If the rmPFK gene has only one promoter,
the skeletal muscle will suffer from PFK deficiency
when the promoter is mutated in such a way that the
expression of the gene is dramatically reduced. This
might result in PFK deficiency disease like the Tarui
disease. However, this can be prevented if the gene has
multiple promoters. Although only one promoter of the
rmPFK gene is active in rabbit kidney tissues, the
down-mutation of the promoter will only result in
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reduced expression from the muscle gene. The
Kidney will still have PFK activity because L type
and C type PFKs are also expressed in Kidney.

SECTION II
PRIM ER EXTENSION AT HIGH TEMPERATURE BY THERMUS
THERMOPHILUS DNA POLYMERASE
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X H T R O D U C T Z O H

Primer extension is a method frequently used in
conjunction with SI mapping or RNase protection analysis in
determining gene transcription start sites. In this method,
an RNA template is reverse-transcribed by either avian
myeloblastosis virus (AMV) reverse transcriptase or Moloneymurine leukemia virus (M-MLV) reverse transcriptase. A
drawback of this method is that secondary structure in the
RNA template may cause the reaction to be prematurely
terminated. To address this problem, Bailey and Davidson
(1976) have reported the use of methylmercuric hydroxide to
destabilize the RNA secondary structure. This compound is
extremely toxic and hence inconvenient to handle. An
alternative method is to raise the temperature of the
extension reaction (Huibregste and Engelke,
and Salvato,

1986; Shimimaye

1989). Elevated temperature would destabilize

the secondary structure in the RNA template and increase
primer extension specificity. Yet the upper temperature
limit is about 50°C for both the M-MLV and AMV reverse
transcriptases, due to the thermal inactivation of these
enzymes.

In my studies of the transcription start sites of

the rabbit muscle phosphofructokinase (PFK) gene, I found
that primer extension was prematurely terminated, even at
50°C (see SECTION I). As predicted by the Fold algorithm in
the GCG program (Zuker and Stiegler,

1981; Freier et al.,

1966), there is a putative secondary structure in the rabbit
muscle PFK mRNA consisting of two stem-loops, including four
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consecutive G-C basepairs immediately upstream of where the
primer extension stopped (Fig. 17 D ) . This prompted me to
search for a thermostable reverse transcriptase which could
perform primer extension at temperatures higher than 50°C.
Recently, thermostable DNA polymerase from Thermus
aguaticus (Tag) has been shown to possess reverse
transcriptase activity in reverse transcription-polymerase
chain reaction

(RT-PCR)

(Jones, 1993; Jones and Foulkes,

1989; Tse and Forget, 1990; Shaffer et al.,

1990). The 94-

kDa DNA polymerase from Thermus thermophilus (Tth) has been
reported to possess even higher reverse transcriptase
activity in RT-PCR experiment than Tag DNA polymerase
and Gelfand,

(Myers

1991) . However, primer extension products

extended from cellular RNA by either Tag or Tth DNA
polymerase have not been fully characterized other than by
RT-PCR. Under the conditions described by Myers and Gelfand
(1991), the Tth DNA polymerase was found not efficient
enough for primer extension analysis of cellular RNA.
Therefore, several conditions for primer extension with this
DNA polymerase were studied using rabbit heart poly(A)+ RNA
and a primer complementary to the rabbit glyceraldehyde 3phosphate dehydrogenase

(GAPDH) gene. Under the optimized

conditions, primer extension with Tth DNA polymerase at 65°C
was as efficient as that with M-MLV reverse transcriptase at
50°C. More importantly, primer extension of the rabbit
muscle PFK mRNA using Tth DNA polymerase at 65°C solved the
problems caused by the RNA secondary structure (see SECTION
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I). This study established a protocol of primer extension to
map transcription start sites at elevated temperature using
the thermostable Tth DNA polymerase. It would also be useful
for the first strand cDNA synthesis in procedures such as
cDNA library construction, anchored-PCR (Loh et al., 1989),
and rapid amplification of cDNA ends (RACE)

{Frohman et al.,

1988) .

MATERIALS

AND

METHODS

Iniyass
Tth DNA polymerase (2.5 units/pl) was purchased from
Perkin Elmer Cetus Co. Superscript II reverse transcriptase
(RNase H deficient, genetically engineered M-MLV reverse
transcriptase) was purchased from Life Science Technologies,
Inc. T4 polynucleotide kinase was purchased from New England
Biolabs,

Inc. Shrimp alkaline phosphatase was purchased from

United States Biochemical Co.

Preparation
marker

of

the

oligonucleotide

primer

end

sise

Primer RabGAPDH (5' OH-CATGTAGACCATGTAGTGGAGGTCAATG-OH
3') was complementary to the 5' sequence of rabbit GAPDH
cDNA (Putney et al., 1983). This oligonucleotide was
prepared by DNA International, Inc. and purified by
polyacrylamide gel electrophoresis as described (Sambrook et
al., 1989). The purified oligo was 5' end-labeled with [y32P]ATP and T4 polynucleotide kinase (Sambrook et al.,

1989).

Size markers were generated by digesting pBR322 plasmid DNA
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with Hpall restriction endonuclease, followed by
dephosphorylation with alkaline phosphatase and
5' end-labeling (Sambrook et al., 1989).

Poly (A) + RNA

preparation

Total RNA from skeletal and cardiac muscle of 10 day old
New Zealand white rabbits was extracted by homogenizing the
tissue in guanidinium isothiocyanate, followed by cesium
chloride gradient centrifugation (Chirgwin et al., 1979).
Poly(A)+ RNA was purified from the total RNA by oligo(dT)
cellulose column chromatography (Sambrook et al., 1989). The
concentration of poly(A)+ RNA was determined by measuring
the absorbance at 260 nm (A26O)•

Primer

extension

by

Tth

DNA

polymerase

Primer extension by Tth DNA polymerase was carried out as
described below or as otherwise stated in the individual
figure legend. The hybridization mix (12 jil) containing 16.7
mM Tris-HCl

(pH 8.3), 150 mM KC1, 5xl04 CPM of primer

RabGAPDH and 3 ng of rabbit poly(A)+ RNA, was heated at 75°C
for 5 min to denature the RNA. After annealing at 65°C for 5
min, the extension mix (8 )il) containing 2.5 mM MnCl 2 » 500
HM each of dATP, dGTP, dCTP, and dTTP, and 5 units of Tth
DNA polymerase was added, and the reaction was overlaid with
20 ill of mineral oil. Primer extension was carried out at
65°C for 1 hr in a Perkin Elmer Cetus thermocycler. After
extension, the mineral oil was carefully removed, and the
residual oil was further extracted with phenol/chloroform
before precipitation

(see below).
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Along with 20 pi of H 2O, 105 pi of RNase reaction mix
(100 pg/ml salmon sperm DNA, 20 pg/ml DNase-free RNase A)
(Ausubel et al., 1993) was added to each primer extension
reaction tube. RNase digestion was carried out at 37°C for
15 min, followed by the addition of 15 pi of 3 M sodium
acetate, pH 5.2. This mixture was extracted once with
phenol/chloroform/isoamyl alcohol and precipitated with
ethanol. Half of the primer extension products were analyzed
as described (Ausubel et al., 1993).

Primer

extension

by

H-MLV

reverse

trsnscriptese

Primer extension was performed basically as described
(Ausubel et al., 1993), except that the extension reaction
was carried out with 100 units of Superscript II reverse
transcriptase at 50°C instead of 42°C. Three pg of poly(A)+
RNA from rabbit heart and 5xl04 CPM of primer were used.
Half of the reaction products were resolved on 6 %
polyacrylamide gels containing 7 M urea,

RESULTS

AND

DISCUSSION

In order to conduct primer extension at elevated
temperature,

it is necessary to find a thermostable reverse

transcriptase. Tth DNA polymerase is a very attractive
enzyme because it is thermostable and possesses higher
reverse transcriptase activity than Tag DNA polymerase
(Myers and Gelfand, 1991), These researchers have reported
successful results using thermostable Tth DNA polymerase in
RT-PCR to detect cellular RNA expression when 400 pg of
total RNA has been used. They have optimized several
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reaction parameters for the reverse transcription using Tth
DNA polymerase. For example, they found that Mn++ is a
better cation than Mg+ +, However, using these conditions,
only a very faint band was visible when the primer extension
reaction was analyzed on a polyacrylamide gel

(Fig, 19, lane

1). These results suggest that under these conditions, the
reverse transcription efficiency by Tth DNA polymerase is
low and is useful only when the reverse transcription is
coupled to the amplification by PCR,
In order to explore the possibility of using Tth DNA
polymerase in mapping transcription start sites, I optimized
the experimental conditions which improved the reverse
transcription efficiency of this enzyme. First, I studied
the performance of Tth DNA polymerase as a reverse
transcriptase at different temperatures using GAPDH specific
primer and rabbit heart poly(A)+ RNA. Although Tth DNA
polymerase has been shown to possess reverse transcriptase
at 70°C (Myers and Gelfand,

1991), this activity was reduced

at increased temperature (Fig. 18). At 70°C and 75°C, only a
very faint band is visible (Fig. 18, lanes 1 4

2). On the

other hand, shorter bands were also present in addition to
the band of 203 bp when the reaction was performed at 55°C
and 60°C, albeit the reverse transcriptase activity of Tth
DNA polymerase was higher at 60°C than at 65°C (Fig. 17,
lane 4 vs lane 3). When the reaction was carried out at
65°C, a predominant band of 203 bp was produced. Therefore,
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Figure 18. Performance of Tth DNA polymerase in primer
extension at different temperatures. Primer extension was
carried out at 75, 70, 65, 60, and 55°C for 60 min (lanes
1, 2, 3, 4, and 5, respectively). In each reaction, 5x10*
CPM of 5'-end labeled oligonucleotide primer complementary
to the rabbit GAPDH cDNA and 3 pg of poly(A+) RNA from
rabbit heart is used, and half of the primer extension
product is loaded. M: DNA size marker generated by
digesting pBR322 DNA with HpaXI restriction endonuclease,
followed by dephosphorylation and S' end labeling with ly32P ]ATP and T4 polynucleotide kinase. Arrow indicates the
primer extension product about 203 bp.
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subsequent primer extension reactions with Tth DNA
polymerase were carried out at 65°C.
Next,

I examined the effect of the extension time on the

amount of the product extended. The results showed that
longer extension times enhanced the intensity of the band,
the one extended for one hr being the strongest

(Fig 19,

lanes 2-4).
Actinomycin D is routinely used in primer extension to
prevent primers to form hairpin when AMV or M-MLV reverse
transcriptase is employed. However our results showed that
this antibiotic reduced the reverse transcription efficiency
of Tth DNA polymerase (lane 1 vs lane 2, Fig. 20). Hence,
this antibiotic is not recommended in the primer extension
reaction when Tth DNA polymerase is employed.
Finally,

I compared the products extended by M-MLV

reverse transcriptase with those by Tth DNA polymerase. The
results showed that there was no visible difference in
intensity and mobility of the products extended by these two
polymerases

(Fig. 21, lane 1 vs lane 2). Primer extensions

were carried out for €0 min with M-MLV reverse transcriptase
at 50°C and for 60 min with Tth DNA polymerase at 65°C.
Extension for one hour has been recommended in primer
extension protocols for AMV or M-MLV reverse transcriptase
(Sambrook et al., 1989; Ausubel et al., 1993). The results
under conditions described here demonstrate that primer
extension with Tth DNA polymerase was as efficient as that
with M-MLV reverse transcriptase. Primer extension by
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Figure 19. Effect of extesion time on the primer extension
by Tth DNA polymerase. Extension reaction was performed at
65°C for 10, 30, and 60 min. (lanes 2, 3, and 4,
respectively). Lane 1: primer extension under the
conditions (at 70°C for 10 min) used by Myer and Gelfand
(1991). M: DNA size marker and see legend to Figure 16 for
detail.
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Figure 20. Effect of actinomycin on primer extension by Tth
DNA polymerase. Extension reaction was carried out at 65°C
for 60 min with (lane 1) and without (Lane 2) actinomycin
(0.15 mg/ml). M: DNA size marker, same as in Figure 18.
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M

1

2

3

Figure 21. Comparison of primer extension of GAPDH RNA by
Tth DNA polymerase and that by MMLV reverse transcriptase.
Lane 1: primer extension of rabbit heart poly(A+) RNA by MMLV reverse transcriptase; lane 2: primer extension of
rabbit heart poly(A+) RNA by Tth DNA polymerase; lane 3:
primer extension of rabbit skeletal muscle poly(A+) RNA by
Tth DNA polymerase. In each reaction# 5x10* CPM of primer
and 3 jig of poly(A+) RNA from rabbit heart, except lane 3 of
panel B from skeletal muscle, is used. Half of the primer
extension product is loaded in each lane. M: size marker,
see Fig. 18 for detail. Arrow indicates the primer
extension product about 203 bp.
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Tth

DNA polymerase using poly(A)+ RNA Isolated from rabbit

skeletal muscle as template also produced a band similar In
mobility to those produced using poly(A)+ RNA from rabbit
heart

(Fig. 21).

In conclusion,

I have optimized conditions to perform

primer extension of cellular RNA at elevated temperatures
using thermostable Tth DNA polymerase. Before optimization,
only a faint band was visible (Fig. 19, lane 1). After
optimization, a strong band was produced (Fig. 19 lane 4).
Furthermore, primer extension using Tth DNA polymerase at
65°C and M-MLV reverse transcriptase at 50°C produced bands
similar in size and intensity (Fig. 21, lane 2 vs lane 1).
This protocol might be useful not only in mapping
transcription start sites, but also in the first strand cDNA
synthesis for cDNA library construction,

for anchored-PCR

(Loh et al, 1969), or for rapid amplification of cDNA ends
(RACE)

(Frohman et al., 1988), especially when secondary

structure of the template RNA may be a potential problem in
the procedure.

CONCLUSIONS AND FUTURE STUDIES
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PFK catalyzes the ATP dependent phosphorylation of F-6-P,
the rate-limiting step in glycolysis. This enzyme is very
interesting to biochemists due to its importance in the
glycolytic pathway and also its allosteric kinetic behavior
responding to various metabolites (Dunaway, 1983). In
addition, this enzyme is physiologically important. The loss
of function of the muscle PFK gene results in Tarui disease
(Tarui et a l ., 1965).
In mammalian tissues, PFK exists as homo- or heterotetramers of three distinct subunits. The three isozymes
exhibit different kinetic properties

(Foe and Kemp,

1985).

The relative levels of these isozymes in a given tissue
determine the composition of PFK tetramers and subsequently
their allosteric behaviors in that tissue (Dunaway,

1983).

Thus the molecular basis for the regulation of glycolysis in
a given tissue lies in the control of the tissue-specific
expression of the genes encoding these three isozymes.
To study the regulation of tissue specific expression of
rabbit muscle PFK gene, the Chang laboratory has previously
cloned the rabbit muscle PFK gene (Lee et al.,

1987) and

recently the two cDNAs of this gene (Li et al., 1990). These
two cDNAs have an identical coding region, but divergent 5'
untranslated regions. However, 1) we do not know whether
these two cDNAs are derived from one or two promoters. If
these cDNAs came from one promoter, their mRNAs would share
the 5' end of the pre-mRNA. 2) the tissue specificity of
these two cDNAs remains elusive.
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IDENTIFICATION

OF

SIX

CDNAS

FOR

THE

RMPFK

GEMS

I have addressed the first question by cloning the 5'
ends of the rmPFK mRNAs using anchored PCR technique. Five
rmPFK cDNAs have been cloned by this technique. Using RTPCR, an additional rmPFK cDNA has been cloned. Therefore,
there are total of six rmPFK cDNAs (SECTION I). The
sequences of the six cDNAs are consistent with the two
previously cloned cDNAs (Li et al., 1990). For example,
cDNA-l identified in this study contains the entire 5' UTR
of cDNA-B of Li et al.
identified by Li et al.

(1990), while the 5' UTR of cDNA-A
(1990) is present in four of the six

cDNAs cloned in this study.

THE 8XX RMPFK mRMAS ARE EXPRE88ED
PROMOTERS OF A SXMGLE GEME

FROM AT

LEAST THREE

Southern blot analysis of rabbit genomic DNA digested
with restriction enzymes indicates that rmPFK is a single
copy gene (Knaak and Chang, unpublished data). The human
muscle PFK has also been shown to be a single copy gene
(Sharma et al., 1990). Therefore, the six cloned rmPFK cDNAs
are produced from a single gene.
We have mapped the transcription start sites of two
downstream promoters of this gene. Promoter a initiates
transcription at a major site 86 bp upstream of the ATG
translational initiation codon, along with several minor
sites (Fig. 16). The 5'-end of cDNA-l identified by anchored
PCR is at the major site. The transcription start sites of a
second promoter initiate transcription from several sites
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about 2 kb upstream of the ATG codon (Fig. 17). The 5'-end
of cDNA-5 is at one of these transcription start sites. The
transcription start sites of the promoter(s) giving rise to
mRNA-c, mRNA-dl and -d2 have yet to be determined. Since the
5' ends of these mRNAs are upstream of promoters a and b,
they can not be transcribed from these promoters. Therefore,
the rmPFK gene expresses these six mRNAs from at least three
and possible four promoters. The promoter(s) that gave rise
to mRNA-c, -dl, and -d2 can be mapped by both primer
extension and SI mapping, techniques that successfully
mapped the transcription start sites of promoter a and
promoter b.

FOUR o r THE SIX RMPFK mRNAS ARE
ALTERNATIVE PRE-aRNA SPLICING

PRODUCED BY

Alignment of the sequence of the cDNAs with that of the
rmPFK genomic DNA showed that two alternative splicing
events of two pre-mRNAs resulted in four of the six rmPFK
mRNAs. First, mRNA-bl is a splicing variant of mRNA-b2; more
specifically, the first intron in the 5' UTR was spliced out
as an intron in mRNA-b2, but retained in mRNA-bl

(Fig,

12),

Also mRNA-dl is a splicing variant of mRNA-d2; exon IB was
not retained in mRNA-d2 (Fig. 12). Alternative splicing
occurred in the

5' UTRs.The human

muscle PFK gene has been

shown to express two of its three mRNAs by alternative
splicing

(Fig. 7; Yamasaki et al., 1991). However, the

alternative splicing events occurred in different pre-mRNAs
in the muscle PFK genes of the two species. In the human
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gene, the pre-mRNA transcribed by the downstream promoter is
alternatively spliced, while in the rabbit gene, the
equivalent

(mRNA-a) is not alternatively spliced, although

5' UTR of the rmPFK mRNA-a and its human counterpart is
highly conserved (82% homology in a region of 450 bp,
including the first coding exon and 300 bp upstream of the
ATG codon). The alternatively spliced mRNAs of the rmPFK
gene are transcribed from promoter b and a promoter further
upstream.

IT 18 UNLIKELY THAT THERE IS A TRANSCRIPTION START
SITE 20 TO 30 BP DOWNSTREAM OP THE TATAAAA SEQUENCE
The 5' end of cDNA-2 is 28 bp downstream of the TATAAAA
sequence. Primer extension using M-MLV reverse transcriptase
also showed a band at this position (y in Fig. 17B).
However, SI mapping analysis clearly showed no band at this
position

(Fig. 17A) . Furthermore, primer extension analysis

at 65°C using Tth DNA polymerase did not show a band at this
position

(Fig. 17C). Therefore,

it is very unlikely that

there is a transcription start site at this position. The
reverse transcription reaction using M-MLV reverse
transcriptase is probably prematurely terminated at this
position,

resulting in a band in the primer extension

analysis and the 5'-end of cDNA-2 at this position.
It is intriguing that there is no transcription start
site 20 to 30 bp downstream of this TATAAAA sequence, since
it matches the TATA box consensus sequence. In addition,
there are multiple putative binding site for transcription
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activators upstream of this sequence. For example, in the
190 bp DNA between promoter b and the TATAAAA sequence,
there are three binding sites for the bHLH myogenic
transcription activators, such as MyoD and myogenin
(Weintraub et al., 1991).
There are several possibilities to explain the apparent
lack of a transcription start site downstream of this
TATAAAA sequence. First of all, there may be a specific
repression sequence near this sequence. This can be
investigated by making a construct fusing the
chloroamphenical acetyltransferase

(CAT) reporter 3' to the

rmPFK genomic DNA sequence 180 bp upstream and 80 bp
downstream of the TATAAAA sequence, since the promoter b is
about 200 bp upstream of the TATAAAA sequence and the splice
site at the 3' end of exon IB is about 88 bp downstream of
the TATAAAA sequence. Linker scanning mutants can be created
based on this construct. Transfection of these constructs to
myoblast C2C12 cells and subsequent CAT assay will probably
reveal the effect of certain mutations at a specific
sequence on the repression of transcription initiation 20 to
30 bp downstream of the TATAAAA sequence,

if there is a

sequence-specific repressor of transcription initiation in
this region of the rmPFK gene. In other words, certain
mutation in this region will leads to transcription
initiation, when a sequence-specific repressor is mutated.
Of course, such mutant should be examined to find out that
gain of transcription initiation is not due to the creation

Ill

of a positive element by the mutation. This can be done by
mutate the putative repressor to other sequences.
Secondly, chromatin structure in this region might
prevent transcription initiation. It has been shown in vitro
that a minimal promoter containing the TATA-box is able to
direct assembly of the transcription initiation complex onto
the DNA template (Buratowski

e t

al., 1989). The first step

is the binding of transcription factor IID (TFIID) to the
TATA-box,

followed by the TFIIA, TFIIB, RNA polymerase II,

and TFIIE. This complex is able to initiate transcription in
the presence of four dNTPs. The binding of TFIID to the TATA
box is essential for transcription initiation. However,
binding of TFIID to a DNA template containing a TATA box and
subsequently the transcription initiation is severely
inhibited after the nucleosome assembly (Workman

e t

al.,

1991; Meinsterernst et a l ., 1990) . However, the binding
remains and potentiates transcription initiation if the
nucleosome is assembled after the TFIID binds to the DNA
(Workman and Roeder,

1987). Recently,

it has been shown that

purified yeast SWI/SNF protein complex can potentiate the
binding of transcription activator GAL4 derivative to
nucleosomal DNA (Cote

e t

al., 1994). Imbalzano et al.(1994)

have examined whether human SWI/SNF complex can facilitate
the binding of TBP to nucleosomal DNA. These researchers
constructed a DNA template of 149 bp containing two
nucleosome positioning sequences

(Shrade and Crothers,

1989)

at the 5' end and the adenovirus major late promoter TATA
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box in the middle (PH MLT). The phasing sequence favors
specific positioning of the histone core. They constructed
two variant templates

(PH mlt9(+3) and PH M L T (+6 ))

positioned the TATA box either 3 or 6 bp, respectively,
closer to the phasing sequences. After nucleosome assembly,
TBP can not bind to the TATA box in all three templates.
Human SWI/SNF complex has been shown to facilitate the
binding of TBP to the TATA box in PH MLT (+3) template.
However, the complex does not facilitate the binding of TBP
to the TATA box in the PH MLT and PH M L T (+6 ) templates
(Imbalzano et al., 1994). These data imply that if a TATA
box is not at a favorable rotation relative to the
nucleosome, even the SWI/SFN proteins can not facilitate the
binding of TBP to the TATA sequence in a DNA template. The
TATAAAA sequence of the rmPFK gene could be in such a
position. There are three sequences near the TATAAAA
sequence that match the consensus nucleosome positioning
sequence. For example, sequence 5'-CCCCCAAT (28 downstream
of the TATAAAA sequence) matches the strong nucleosome
positioning consensus sequence (G/C)3NN(A/T )3 (Shrade and
Crothers,

1989).

If the nucleosome is repressing transcription, a naked
DNA template of the above mentioned construct can be used
which has a CAT reporter fused 3' to an rmPFK gene fragment
about 180 bp upstream and 80 bp downstream of the TATAAAA
sequence. This template should initiate transcription in in
vitro transcription system using histone-depleted nuclear
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extract from rabbit muscle# since there are three putative
MyoD binding sites in this rmPFK gene fragment.

THE SIX RMPFK MRNAS
SPECIFIC MANNER

ARE

MOT

EXPRESSED

IN

SAME

TISSUE-

Northern blot and RT-PCR analysis revealed that the six
rmPFK mRNAs are expressed in a tissue-specific manner: mRNAbl, -b2, and -c are skeletal muscle specific <Figs. 14 and
15). mRNA-a was also found expressed only in skeletal muscle
by Northern blot analysis (Fig. 14). However, RT-PCR
experiment showed that this mRNA is also expressed in heart
(Fig. 15A). This discrepancy might be due to the high
sensitivity of RT-PCR compared to Northern blot analysis.
mRNA-dl was only detected in skeletal muscle, heart, and
brain tissues, but not in liver and kidney, while mRNA-d2
was detected in all five rabbit tissues examined (Fig. 15).
The hmPFK gene has also been shown by RT-PCR to be expressed
in all seven human tissues examined (Nakajima et al., 1990).
The pattern of the tissue-specific expression of the
rmPFK mRNAs described here is consistent with that of the
rmPFK protein

(Tsai and Kemp, 197 3). The rmPFK has been

shown to be the predominant PFK in rabbit skeletal muscle.
This isozyme has also been shown to be expressed in brain,
heart, kidney, and minimally in liver tissues

(Tsai and

Kemp, 1973). A similar pattern of expression of the muscle
type PFK has also been shown in humans (Dunaway et al.,
1988) and in rats (Dunaway and Kasten, 1987).
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THE DIFFERENT 5' UTRS OF THE SIX RMFFK aRNAE HAT FLAT
A ROLE IN THE STABILITY AND TRANSLATIONAL EFFICIENCY
OF THESE aRNAS
The six different mRNAs of the rmPFK gene have
different 5' UTRs. There is one short open reading frame
(ORF) of 72 nucleotides in the 5' UTR of mRNA-c (for
sequence,

see Fig. 11). In the 5' UTR of mRNA-bl, there

are three ORFs of 15, 12, and 60 nucleotides. Four short
ORFs in the 5' UTR of the yeast GCN4 mRNA have been shown
to regulate the translation of the GCN4 ORF {Hinnebusch et
a l ., 1993). Whether the short ORFs in the 5' UTRs of the
rmPFK mRNA-bl and mRNA-c play any role in the stability
and translational efficiency of the PFK ORF is not known.
This could be addressed by the following experiments.
The 5' UTRs of the different rmPFK cDNAs will be fused 5'
to the CAT coding region. These chimeras will be driven
by a common promoter, such as adenovirus major late
promoter. The stabilities of the chimeric mRNAs can be
deduced by examining the levels of these chimeric
mRNAs before and at different times after the
addition of Actinomycin D, which stops transcription
by RNA polymerase II. The effects of these different UTRs
on the translational efficiency can also be studied using
these constructs. The CAT enzyme activity of the different
constructs and the steady state level of the mRNAs would
reveal the translational efficiency of the different
chimeric mRNAs.
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PRIMS It BXTEHSIOM AT HIGH TEMPERATURE
THERMOSTABLE TTH DMA POLYMERASE
In this dissertation research,

USING

I have developed a

protocol tor primer extension at high temperature. Primer
extension at 50°C of rmPFK around the TATAAAA sequence
resulted in prematurely terminated products when M-MLV
reverse transcriptase was used. Higher temperature should
destabilize the secondary structure and reduce the artifact.
However, both AMV and M-MLV reverse transcriptases have been
found inactivated at temperatures higher than 50°C (Gibco
BRL catalog). Tth DNA polymerase has been reported to
possess reverse transcriptase activity and can tolerate high
temperature

(Myers and Gelfand,

1991). Primer extension

under the conditions in the existing protocol
Gelfand,

(Myers and

1991) resulted in a very faint band. After

optimization, primer extension using Tth DNA at 65°C
produced a band similar in size and intensity to that using
M-MLV reverse transcriptase at 50°C. Using the optimized
protocols developed in this study (SECTION II), primer
extension at 65°C using Tth DNA polymerase resolved the
problem caused by the secondary structure in the rmPFK mRNA
(SECTION I). The improved method may be useful for other
procedures such as cDNA library construction and anchored
PCR. The usefulness of this protocol has been shown in
anchored PCR experiment described in SECTION I of this
dissertation.

REFERENCES

Ausubel, F. M., Brent, R., Kingston, R, E., Moore, D. D.,
Seidman, J. G., Smith, J. A., and Struhl, K. (1993) Current
Protocols in Molecular Biology. Wiley, Mass.
(1976) Anal. Biochem. 70, 75-

Bailey, J. M. and Davidson, N.
85 .
Baker, B.

(1989) Nature 340, 521-524.

Bloxham, D. P. and Lardy, H. A.
Press, New York, 239-278.

(1973) The Enzymes, Academic

Bodary, S., Grossi, G., Gagenbuchle, O., and Wellarer, P.
K., (1985) J. M o l . Biol. 182, 1-10.
Brady, H. J. M., Lowe, N., Sowden, J. C., Edwards, M., and
Butterworth, P. H., W. (1991) Biochem. J. 277, 903-905.
Breathnach, R,, and Chambon, P.
50, 349-383.

(1981) Annu. Rev. Biochem.

Buratowski, S., Hahn, S., Guarente, L., and Sharp, P. A.
(1989) Cell 56, 549-561.
Chang, D. D. and Sharp, P. A.

(1989) Cell 59, 789-795.

Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter,
W.J., (1979) Biochem. 18, 5292.
Claus, T. H., El-Maghrabi, M. R., Regen, D. M., Stewart, B.,
McGrane, M., Kountz, P., Nyfeler, F., Pilkis, J., and
Pilkis, S. J. (1981) Curr. Top. Cell. Regul. 23, 57-68.
Colombo, G. Tate, P. W., Girotti, A. W., and Kemp, R. G.
(1975) J. Biol. Chem. 250, 9404-9412.
Concordet, J.-P., Salminen, M., Demingon, J., Moch, C.,
Maire, P., Kahn, A., and Daegelen, D. (1993) Mol. Cell.
Biol. 13 9-17.
Corbin, v., and Maniatis, T,

(1989). Nature 337, 279-282.

Cote, J., Quinn, J., Workman, J. L., and Peteson, C. L.
(1994) Science 265, 53-60.
Darville, M. I., Crepin, K. M., Hue, L., Rousseau, G. G.
(1989) Proc. Natl. Acad. Sci. USA. 86 , 6543-6547.

116

117
Deng# G.R., and Wu, R,
116.

(1983) Methods in Enzymol. 100, 96-

Donze, D., Townes, T. M., and Bieker, J. J,
Chem. 270, 1955-199.

(1995) J . Biol.

Dunaway, G. A, and Kasten, T. P. (1987) Biochem. J, 242, 667671 .
Dunaway, G .A . (1983) Mol and Cell. Biochem. 52, 75-91.
Dunaway, G, A., Kasten, T. P., Sebo, T., and Trapp, R.
(1988) Biochem. J. 251, 677-683.
Dynan, W. S.

(1986) Trends Genet. 2, 196-197.

El-Maghrabi, M. R., Colosia, A. D., Tauler, A., and Pilkis,
S, J. (1990) in Fructose 2, 6-Bisphosphate (Pilkis, S. J.
ed.) pp. 87-124 CRC Press, Boca Raton.
Enver, T., Raich, N ., Ebens, A. J., Papayannopoulou, T.,
Costantini, F., and Stamatoyannopoulos, G. (1990). Wature,
344, 309-313.
Estes, P. A., Keves, L. N., and Schedl, P.
B i o l . 15, 904-917.

(1995) Mol. Cell.

Evans, P.R., Farrants, G. W., and Hudson, P. J.
Trans Roy. Soc. London ser. B, 293, 53-62.
Fischer, J. A. and Maniatis, T.

(1981) Phil.

(1986) EMBO J. 5, 1275-1289.

Fischer, L. E., Hagen, F. S., and Garber, R. L.
47, 1017-1023.

(1986) Cell

Fisher, U., Meyer, S., Teufel, M., Heckel, C., Luhrmann, R.,
and Rautmann, G. (1994)
EMBO J. 13, 4105-4112.
Foe , L. G. and Kemp,R. G.
730.

(1985) J. Biol. Chem.

Foe, h. G., Latshaw, S. P., and Kemp, R. G.
22, 4601-4606.
Foley, K. P. and Engel, J. D.
744 .

260, 726-

(1983) Biochem.

(1992) Genes and Dev. 6, 730-

Freier, S. M,, Kierzek, R., Jaeger, J. A., Sugimoto, N.,
Caruthers, M. H., Neilson, T., and Turner, D. H. (1986)
Proc. Natl. Acad. Sci . USA. 83, 9373-9377.
Frohman, M. A., Dush, M. K., and Martin, G. R.
Natl. Acad. Sci. USA. 85, 8998-9002.

(1988)

Proc.

110
Fu, X. - D ., Mayeda, A., Maniatis, T., and Krainer,
(1992) Proc. Natl. Acad. Sci. U.S.A. 89, 11224-11228.
Fu, X. D.

A.

R.

(1993) Nature 365,82-85.

Garland, P. B., Randle, P. J., and Newsholme, E. A , (1963)
Wature 200, 169-170.
Gautron, S.,.Maire, P., Hakim, V., and Kahn, A.
Acids Res. 19, 767-774.
Ge, H. and Manley, J. L.

(1991) Nucl.

(1990) Cell 62, 25-34.

Ge, H., Zuo, P., and Manley, J. L.

(1991) Ceil 66 , 373-382.

Gehnrich, S. C., Gekakis, N., and Sul, H. S.
Chem. 263, 11755-11759.
Gekakis, Gehnrich, S. C., and Sul, H. S.
Chem. 264, 3658-3661.

(1988) J. Biol.

(1989) J. Biol.

Gekakis, Johnson, R. C., Jerkins, A., Mains, R. E., and Sul,
H. S. (1994) J. Biol. Chem. 269, 3348-3355.
Gekakis, N. and Sul, H. S.

(1994) Biochem. 33, 1771 - 1 7 7 7 .

Gonzalez, F. and Kemp, R. G.
1493-1497.
Green, M. R.

(1978) J. Biol. Chem. 253,

(1991) Ann. Rev. Cell Biol. 7, 559-599.

Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M.,
Haubmann,
I., Matzku, S., Wenzel, A., Ponta, H., and
Herrlich, P. (1991) Cell 65, 13-24.
Hanson , R. L ., Rudolph, F. B., and Lardy, H. A.
Biol. Chem. 248, 7852-7859.
Hayward, W, S., Neel, B. G., and Astrin, S. M.
Nature 290, 475-480.
Hellinga, H. W. and Evans, P. R.
149, 363-373.
Hinnebusch A.
Feng, L., and
Regulation of
Plenum Press,

(1973)

J.

(1981)

(1985) Eur. J. Biochem.

G., Wek, R. C., Dever, T. E., Cigan, A. M.,
Donahue, T. F. (1993) in Translational
Gene Expression 2. (Ilan, J. ed.) pp. 87-115.
New York.

Hotta, K., Nakajima, H., Yamasaki, T., Hamaguchi, T,,
Kuwajima, M., Noguchi, T., Tanaka, T., Kono, K., andTarui,
S. (1991) Eur. J. Biochem. 202, 293-298.
Huibregste J. M, and Engelke, D. R.

(1986) Gene 44, 151-158.

119

Imbalzano, A. N,, Kwon, H., Green, M. R., and Kingston, R.
E. (1994) Wature 370, 481-485.
Jones, M. D.

(1993) Methods Enzymol. 218, 413-419.

Jones, M. D., and Foulkes, N. S.
8387-8388.
Kandels-Lewis,
2039.
Kemp, R. G.

(1989) Mucl. Acids Res. 17,

S. and Seraphin, B.

(1993) Science 262, 2035-

(1971) j. Biol. Chem. 246, 245-252.

Keyes, L. N., Cline, T. W., and Schedl, P.
933-943.
Kjem, J. and Sharp, P. A.

(1992) Ceii 68 ,

(1993) J. Virol. 67, 4769-4776.

Kjem, J., Frankel, A. D., and Sharp, P. A.
169-178.

(1991) Cell 67,

Kohtz, J. D., Jamison, S.
Luhrmann, R., Garcia-Bianco,
(1994) Nature 368, 119-124.

F., Will, C. L., Zuo,
P.,
M,, A., and Manley, J.
L.

Krainer, A. R., Conway, G. C.,
35-42.

and Kozak, D.

Krainer, A. R., Mayeda,
Cell 66 , 383-394.

A., Kozak,

Lamm, G. M. and Lamond, A. I.
173, 247-265.

(1990)

Cell 62,

D., and Binns, G.

(1991)

(1993) Biochem. Biophys. Acta

Lardy, H. A. and Parks, R. E. (1956) In Enzymes: Units of
Biological Structure and Function. (Gaebler, O. H., ed.),
pp. 584-587. Academic Press, New York.
Layzer, R. B., Rowland, I. P., and Bank, W. J.
Biol. Chem. 244, 3823-3831.
Layzer, R. B., Rowland, 1. P., and Ranny, H. M.
Weurol. 17, 512-523

(1969) J.
(1967) Arch.

Lee, C.P., Kao, M.C., French, B.A., Putney, S.D., and Chang,
S.H. (1987) J. Biol. Chem. 262, 4195-4199.
Lesser, C. F. and Guthrie, C.

(1993) Science 262, 1982-1988.

Levanon, D., Danciger, E., Dafni, N., Bernstein, Y., Elson,
A., Moens, W., Brandeis, M., and Groner, Y. (1989) DNA 8 ,
733-743.

120
Li, J.Y., Chen, Z,,Lu, L., Byrnes, M ., and Chang, S.H.
(1990> Biochem. Biophys. Res. Comm. 170, 1056-1060.
Li, Y., Valaitis, A.P., Latshaw, S. P., Kwiatkowska, D.,
Tripathi, R.L., Campbell, M . C ., and Kemp, R . G . {1994) J.
Biol. Chem. 269, 5781-5787.
Loh, E.Y., Elliott, J.F., Cwirla, S., Lanier, L.L., and
Davis, M.M. (1989) Science 243, 217-243.
Lowry, O. H. and Passonneau, J.V.
2268-2279.

(1966) J. Biol. Chem. 241,

Lu, J., Lee, W., Jiang, C., and Keller, E. B.
Biol. Chem. 269, 5391-5402.
Maniatis, T.

(1994) J .

(1991) Science 2S1, 33-34.

Mansour, T. E. and Ahlfors, C. E.
2523-2533.

(1968) J. Biol. Chem. 243,

Marchuk, D., Drumm, M., Saulino, A., and Collins, F. S.
(1991) Nucl. Acids Res. 19, 1154.
Mayeda, A. and Krainer, A. R.
Mayeda, A., Helfman, D. M.,
Cell. Biol. 13, 2993-3001.

(1992) Cell 68, 365-375.
and Krainer,

A, R. (1993) Mol.

Mayeda, A., Zahler,
A. M., Krainer, A. R., and Roth,
(1992) Proc. Natl. Acad. Sci. USA. 89, 1301-1304.
Meinsterernst, M., Horikoshi, M., and Roeder, R. G.
Proc. Natl. Acad. Sci. USA. 87, 9153-9157.

M. B.

(1990)

Moore, M. L., Query, C. C.,and Sharp, P. (1993) In the RNA
world, Gesteland, R. F. and Atkins, J. F. eds. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, New York. pp.
303-358.
Mukai, T., Arai, Y., Yatski, H., Joh, K., and Hori, K.
(1991) Eur. J. Biochem. 195, 781-787.
Myers, T. W, and Gelfand, D. H.
7661-7666.

(1991) Biochemistry 30,

Nadal-Ginard,
B.,
Smith,
C. W., Patton,
J. G.,
Breitbart, R. E. (1991) Adv. Enzymol. Reg. 31, 261-286.

and

Nakajima, H., Kono, N., Yamasaki, T., Hamaguchi, T., Hotta,
K., Kuwajima, M., Noguchi, T., Tanaka, T., and Tarui, S.
(1990) Biochem. Biophys. Res. Commun. 173, 1317-1321.
Newman, A. J. and Norman, C.

(1992) Cell 68 , 743-754.

121

Parmeggiani, A. and Bowman, R. H.
Res. Commun. 12, 268-273.
Passonneau, J. V. and Lowry, 0. H.
Res. Commun. 13, 372-379.

(1963) Biochem. Biophys.
(1963) Biochem. Biophys.

Pilkis, S. J. (1990) Fructose 2, 6-bisphosphate. CRC Press,
Boca Raton, Florida.
Pilkis, S. J. and El-Maghrabi, M. R.
Biochem. 57, 755-783.

(1988) Ann. Rev.

Pilkis, S. J., El-Maghrabi, M, R., Pilkis, J., and Claus, T.
(1981) J. Biol. Chem. 255, 3619-3622.
Poorman, R. A., Randolph, A., Kemp, R. G., and Heinrikson,
R. L. (1984) Nature 309, 467-469.
Putney, S. D., Herlihy, W. C., and Schimmel, P.
Wature 302, 718-721.

(1983)

Rajagopalan, S., Wan D.-F., Habib, G. M., Sepulveda, A. R,,
McLeod, M. R., Lebovitz, R. M., and Lieberman, M. W. (1993)
Proc. Na t l . Acad. Sci.
USA. 90, 617 9-6183.
Rio, D. C.

(1992) Gene

Expr. 2, 1-5.

Rongnoparut, P., Verdon, C. P., Gehnrich, S. C., and Sul, H.
S. (1991) J. Biol. Chem. 266, 8086-8091.
Rudy, W., Hofmann, M., Schwartz-Albiez, R., Zoller, M.,
Heider, K.-H., Ponta,
H,, and Herrlich,P. (1993) Cancer
Res. 53, 1262-1268.
Saiki, R.K., Gelfand, D. H,, Stoffel, S., Scharf, S. J.,
Higuchi, R., Horn, G, T., Mullis, K. B,, and Erlich, H. A.
(1988) Science 239, 487-490.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989)
Molecular Cloning: A Laboratory Manual. 2nd Ed., Cold Spring
Harbor Laboratory Pre 3 s, Cold Spring Harbor.
Sanger, F., Nicklen, S., and Colson, A. R.
Natl. Acad. S c i . USA. 74, 5463-5467.
Schibler, U and Sierra, F.
237-257.

(1977) Proc.

(1987) Annual Rev. Genet. 21,

Schirmer, T. and Evans, P. R.

(1990) Nature 343, 141-145

Sepulveda, A. R., Carter, B. Z., Habib, G. M., Lebovitz, R.
M., and Lieberman, M. W. (1994) J. Biol. Chem. 269, 1069910705.

122

Shaffer, A. L., Hojnar, W., and Nelson, W.
Biochem. 190, 292-296.

(1990) A n a l .

Sharma, P . M., Reddy, G . R., Babior, B . M., and McLachlan,
A. (1990) J. Biol. Chem. 265, 9006-9010.
Sharma, P. M., Reddy, G, R., Vora, S., Babior, B. M., and
McLachlan, A. (1989) Gene 77, 177-183.
Shimomaye, E. and Salvato, M.
28.

(1989) Gene Anal. Tech. 6 , 25-

Shirakihara Y. and Evens, P. R.
973-994.

(1988) J. M o l . Biol. 204,

Shrade, T. E. and Crothers, D. M.
Sci. USA. 86, 7418-7422.
Siliciano,
1267.

and Guthrie, C.

(198 9) Proc. Natl. Acad.

(1988) Genes and Dev. 2, 1258-

Smale, S. T. and Baltimore, D.

(1989) Cell 57,,

103-113.

Stauffer, J. K., Colbert, M. C., and Ciejek-Baez, E.
J. Biol. Chem. 265, 11773-11782.
Steitz, J. A.

(1990)

(1992) Science 257, 888-889.

Strahle, U., Schmidt, A, Kelsley, G., Stewart, F., Cole, T.
J., Schmid, W , , and Schutz, G. (1992) Proc. Natl. Acad. Sci.
USA. 89, 6731-6735.
Tabor, S. and Richardson, C. C.
6447-6458.

(1989) J. Biol. Chem. 264,

Tarui, S., Kono, N., Nasu, T., and Nishikawa, M.
Biochem. Biophys. Res. Commun. 34,77-83.

(1969)

Tarui, S., Okuno, G., Ikura, Y,, Tanaka, T., Suda, M., and
Nishikawa, M. (1965) Biochem. Biophys. Res. Commun. 19, 517523.
Tian, M. and Maniatis, T.

(1993) Cell. 74, 105-114.

Toh, Y., Yamamoto, M., Endo, H., Misumi, Y., and Ikehara, Y.
(1989) Bur. J. Biochem. 182, 231-237.
Tornheim, K. and Lowenstein, J. M.
251, 7322-7328.
Tsai, M. Y. and Kemp, R. G.
7 92 .

(1976) J. Biol. Chem.

(1973) J. Biol. Chem. 248, 785-

123
Tsai/ M. Y. and Kemp, R . G.
6595.

(1974) J. Biol. Chem. 249, 6590-

Tse, W. T. and Forget, B. G.
Uyeda, K.

(1990) Gene 8 S, 293-296.

(1979) Adv. Enzymol. 48, 192-244.

Valdenaire, 0., Vernier, P., Maus, M., Dumas, J.
Mallet, J. (1994) Eur. J. Biochem. 220, 577-584.

D. M., and

Valdez, B. C., French, B. A., Younathan, E. S., and Chang,
S. H. (1989a) J. Biol Chem. 264, 131-135.
Valdez, B. C., Chen, Z., Sosa, M.G., Younathan, E. S., and
Chang, S. H. (1989b) Gene 76, 167-169.
Van Schaftingen, E., Hue, L., and Hers, H. G.
Biochem. J, 192, 887-895.
Wassarman, D. A. and Steitz,
1925.

J. A.

(1980)

(1992) Science 2S7, 1918-

Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause,
M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R.,
Hollenberg, S., Zhuang, Y., and Lassar, A. (1991) Science
251, 761-766,
Workman, J. L. and Roeder, R. G.

(1987) Cell 51, 613-622.

Workman, J. L., Talor, I. C., and Kingston R. E,
64, 533-544.
Wu, J. and Manley, J. L.

(1991) Cell

(1989) Genes Dev. 3,1553-1561.

Wu, J. Y. and Maniatis, T.

(1993) Cell 75, 1061-1070.

Yamasaki, T,, Nakajima, H., Kono, N,, Hotta, K., Yamada, K.,
Imai, E., Kuwajima, M., Noguchi, T., Tanaka, T., and Tarui,
S. (1991) Gene 104, 277-282.
Zahler, A. M., Lane, W. S., Stolk,
(1992) Genes Dev. 5, 837-846.

J. A.,

and Roth,

M. B.

Zahler, A. M,, Neugebauer, K. M., Lane, W. S., and Roth, M.
B. (1993) Science 260, 219,222.
Zuo, P. and Manley, J. L.

(1993) EMBO J. 12, 4727-4737.

Zuo, P. and Manley, J. L.
91, 3363-3367.

(1994) Proc. Natl. Acad. Sci. USA.

Zuker, M. and Stiegler, P.
149.

(1981) Nucl. Acids Res. 9, 133-

APPENDIX
RESTRICTION MAP OF THE 5 ’ FLANKING REGION OF THE
RABBIT MUSCLE PHOSPHOFRUCTOKINASE GENE
This map was generated using the GCG software (Zuker and
Stiegler,

1981).
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